ONTOLOGY REPORT - ANNOTATIONS
Term: genistein
Accession: CHEBI:28088
browse the term
Definition: A member of the class of 7-hydroxyisoflavones that is 7-hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties.
Synonyms: exact_synonym: 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
related_synonym: 4',5,7-trihydroxyisoflavone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; C15H10O5; InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H; InChIKey=TZBJGXHYKVUXJN-UHFFFAOYSA-N; Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O; Prunetol; Sophoricol
alt_id: CHEBI:24204; CHEBI:42763; CHEBI:5302
xref_casrn: 446-72-0
xref: Beilstein:263823 "Beilstein Registry Number"; ChEMBL:102658 "ChEMBL COMPOUND"; ChemIDplus:446-72-0 "CAS Registry Number"; CiteXplore:10741415 "PubMed citation"; DrugBank:DB01645 "DrugBank"; KEGG COMPOUND:446-72-0 "CAS Registry Number"; KEGG COMPOUND:C06563 "KEGG COMPOUND"
xref_mesh: MESH:D019833
xref: PDBeChem:GEN "PDBeChem"; Wikipedia:Genistein "Wikipedia"
genistein
G
ABCA1
ATP-binding cassette, sub-family A (ABC1), member 1
multiple interactions
EXP
9
107,543,283
107,690,527
RGD:6480464
CTD
G
ABCA1
ATP-binding cassette, sub-family A (ABC1), member 1
increases expression
EXP
9
107,543,283
107,690,527
RGD:6480464
CTD
G
ABCB4
ATP-binding cassette, sub-family B (MDR/TAP), member 4
decreases expression
ISO
7
87,031,361
87,105,019
RGD:6480464
CTD
G
ABCC1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
affects activity
EXP
16
16,043,434
16,236,931
RGD:6480464
CTD
G
ABCC1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
decreases activity
EXP
16
16,043,434
16,236,931
RGD:6480464
CTD
G
ABCC1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
decreases activity
EXP
16
16,043,434
16,236,931
RGD:6480464
CTD
G
ABCC1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
decreases activity
ISO
16
16,043,434
16,236,931
RGD:6480464
CTD
G
ABCC1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
multiple interactions
ISO
16
16,043,434
16,236,931
RGD:6480464
CTD
G
ABCC13
ATP-binding cassette, sub-family C (CFTR/MRP), member 13, pseudogene
increases expression
EXP
21
15,646,120
15,673,707
RGD:6480464
CTD
G
ABCC2
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
multiple interactions
EXP
10
101,542,463
101,611,662
RGD:6480464
CTD
G
ABCC3
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
decreases expression
EXP
17
48,712,218
48,769,063
RGD:6480464
CTD
G
ABCC9
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
increases expression
ISO
12
21,950,323
22,089,628
RGD:6480464
CTD
G
ABI1
abl-interactor 1
increases expression
EXP
10
27,035,525
27,150,016
RGD:6480464
CTD
G
ABP1
amiloride binding protein 1 (amine oxidase (copper-containing))
increases expression
ISO
7
150,549,573
150,558,379
RGD:6480464
CTD
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
multiple interactions
ISO
17
61,554,422
61,575,741
RGD:6480464
CTD
G
ACP5
acid phosphatase 5, tartrate resistant
decreases expression
ISO
19
11,685,475
11,689,801
RGD:6480464
CTD
G
ACPP
acid phosphatase, prostate
decreases expression
EXP
3
132,036,211
132,087,146
RGD:6480464
CTD
G
ACSL3
acyl-CoA synthetase long-chain family member 3
increases expression
EXP
2
223,725,732
223,808,119
RGD:6480464
CTD
G
ACSS1
acyl-CoA synthetase short-chain family member 1
increases expression
ISO
20
24,986,866
25,038,818
RGD:6480464
CTD
G
ACTA2
actin, alpha 2, smooth muscle, aorta
increases expression
ISO
10
90,694,831
90,751,147
RGD:6480464
CTD
G
ACVR2A
activin A receptor, type IIA
decreases expression
ISO
2
148,602,570
148,688,393
RGD:6480464
CTD
G
ADAM15
ADAM metallopeptidase domain 15
decreases expression
EXP
1
155,023,748
155,035,252
RGD:6480464
CTD
G
ADAM9
ADAM metallopeptidase domain 9
decreases expression
ISO
8
38,854,505
38,962,780
RGD:6480464
CTD
G
ADAMTS7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
increases expression
EXP
15
79,051,545
79,103,773
RGD:6480464
CTD
G
ADAMTS9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
increases expression
EXP
3
64,501,330
64,673,365
RGD:6480464
CTD
G
ADD2
adducin 2 (beta)
multiple interactions
EXP
2
70,889,216
70,995,375
RGD:6480464
CTD
G
ADRA2C
adrenoceptor alpha 2C
decreases expression
ISO
4
3,768,296
3,770,253
RGD:6480464
CTD
G
APEH
N-acylaminoacyl-peptide hydrolase
increases expression
ISO
3
49,711,435
49,720,934
RGD:6480464
CTD
G
APLP2
amyloid beta (A4) precursor-like protein 2
decreases expression
EXP
11
129,939,716
130,014,706
RGD:6480464
CTD
G
APOB
apolipoprotein B (including Ag(x) antigen)
increases expression
ISO
2
21,224,301
21,266,945
RGD:6480464
CTD
G
APOBEC3B
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
increases expression
EXP
22
39,378,404
39,388,784
RGD:6480464
CTD
G
APOC1
apolipoprotein C-I
decreases expression
ISO
19
45,417,921
45,422,606
RGD:6480464
CTD
G
AR
androgen receptor
decreases expression
EXP
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AR
androgen receptor
multiple interactions
EXP
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AR
androgen receptor
increases activity
EXP
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AR
androgen receptor
increases expression
EXP
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AR
androgen receptor
decreases expression
ISO
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AR
androgen receptor
affects binding
ISO
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AR
androgen receptor
decreases expression
ISO
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AREG
amphiregulin
increases expression
EXP
4
75,310,853
75,320,726
RGD:6480464
CTD
G
ARF1
ADP-ribosylation factor 1
decreases expression
EXP
1
228,270,361
228,286,913
RGD:6480464
CTD
G
ARG1
arginase, liver
increases expression
ISO
6
131,894,344
131,905,472
RGD:6480464
CTD
G
ARHGDIA
Rho GDP dissociation inhibitor (GDI) alpha
decreases expression
EXP
17
79,825,597
79,829,282
RGD:6480464
CTD
G
ARL3
ADP-ribosylation factor-like 3
increases expression
EXP
10
104,433,484
104,474,190
RGD:6480464
CTD
G
ARPC1B
actin related protein 2/3 complex, subunit 1B, 41kDa
increases expression
ISO
7
98,972,298
98,992,424
RGD:6480464
CTD
G
ARSD
arylsulfatase D
decreases expression
EXP
X
2,822,011
2,847,416
RGD:6480464
CTD
G
ASAH1
N-acylsphingosine amidohydrolase (acid ceramidase) 1
decreases expression
EXP
8
17,913,925
17,942,507
RGD:6480464
CTD
G
ASIP
agouti signaling protein
multiple interactions
ISO
20
32,848,171
32,857,148
RGD:6480464
CTD
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
7
97,481,429
97,501,854
RGD:6480464
CTD
G
ASPM
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
affects expression
EXP
1
197,053,257
197,115,824
RGD:6480464
CTD
G
ASPM
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
increases expression
EXP
1
197,053,257
197,115,824
RGD:6480464
CTD
G
ASRGL1
asparaginase like 1
increases expression
EXP
11
62,104,774
62,160,887
RGD:6480464
CTD
G
ASS1
argininosuccinate synthase 1
increases expression
EXP
9
133,320,094
133,376,661
RGD:6480464
CTD
G
ASS1
argininosuccinate synthase 1
increases expression
ISO
9
133,320,094
133,376,661
RGD:6480464
CTD
G
ATAD2
ATPase family, AAA domain containing 2
increases expression
EXP
8
124,332,090
124,408,705
RGD:6480464
CTD
G
ATF3
activating transcription factor 3
decreases expression
EXP
1
212,738,676
212,794,119
RGD:6480464
CTD
G
ATG5
autophagy related 5
increases expression
EXP
6
106,632,352
106,773,695
RGD:6480464
CTD
G
ATM
ataxia telangiectasia mutated
affects response to substance
ISO
11
108,093,559
108,239,826
RGD:6480464
CTD
G
ATN1
atrophin 1
decreases expression
EXP
12
7,033,626
7,051,484
RGD:6480464
CTD
G
ATP1B1
ATPase, Na+/K+ transporting, beta 1 polypeptide
decreases expression
EXP
1
169,075,947
169,101,960
RGD:6480464
CTD
G
ATP1B3
ATPase, Na+/K+ transporting, beta 3 polypeptide
increases expression
ISO
3
141,595,470
141,645,382
RGD:6480464
CTD
G
ATP5E
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit
increases expression
EXP
20
57,603,733
57,607,422
RGD:6480464
CTD
G
ATP5G2
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)
increases expression
ISO
12
54,058,944
54,070,512
RGD:6480464
CTD
G
ATP5O
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
increases expression
ISO
21
35,275,757
35,288,158
RGD:6480464
CTD
G
ATP5O
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
increases expression
ISO
21
35,275,757
35,288,158
RGD:6480464
CTD
G
ATP6AP1
ATPase, H+ transporting, lysosomal accessory protein 1
increases expression
ISO
X
153,656,978
153,664,862
RGD:6480464
CTD
G
ATP6V0A2
ATPase, H+ transporting, lysosomal V0 subunit a2
multiple interactions
EXP
12
124,196,865
124,246,302
RGD:6480464
CTD
G
ATP6V1A
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A
increases expression
ISO
3
113,465,866
113,530,905
RGD:6480464
CTD
G
ATP6V1B2
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2
increases expression
ISO
8
20,054,704
20,079,207
RGD:6480464
CTD
G
ATXN2L
ataxin 2-like
decreases expression
EXP
16
28,834,369
28,848,558
RGD:6480464
CTD
G
AURKA
aurora kinase A
increases expression
EXP
20
54,944,445
54,967,351
RGD:6480464
CTD
G
AURKB
aurora kinase B
increases expression
EXP
17
8,108,049
8,113,944
RGD:6480464
CTD
G
BASP1
brain abundant, membrane attached signal protein 1
decreases expression
EXP
5
17,217,750
17,276,943
RGD:6480464
CTD
G
BAX
BCL2-associated X protein
multiple interactions
EXP
19
49,458,117
49,465,055
RGD:6480464
CTD
G
BAX
BCL2-associated X protein
multiple interactions
EXP
19
49,458,117
49,465,055
RGD:6480464
CTD
G
BAZ1A
bromodomain adjacent to zinc finger domain, 1A
multiple interactions
EXP
14
35,221,937
35,344,853
RGD:6480464
CTD
G
BAZ2A
bromodomain adjacent to zinc finger domain, 2A
decreases expression
EXP
12
56,989,380
57,030,163
RGD:6480464
CTD
G
BCAT1
branched chain amino-acid transaminase 1, cytosolic
increases expression
ISO
12
24,962,958
25,102,393
RGD:6480464
CTD
G
BCHE
butyrylcholinesterase
increases expression
EXP
3
165,490,692
165,555,253
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
decreases expression
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
ISO
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
decreases expression
ISO
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
multiple interactions
EXP
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
multiple interactions
EXP
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
decreases expression
EXP
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
multiple interactions
ISO
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
decreases expression
ISO
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL3
B-cell CLL/lymphoma 3
multiple interactions
ISO
19
45,251,978
45,263,301
RGD:6480464
CTD
G
BEX4
brain expressed, X-linked 4
decreases expression
ISO
X
102,470,020
102,472,128
RGD:6480464
CTD
G
BGLAP
bone gamma-carboxyglutamate (gla) protein
multiple interactions
ISO
1
156,211,951
156,213,123
RGD:6480464
CTD
G
BGLAP
bone gamma-carboxyglutamate (gla) protein
multiple interactions
ISO
1
156,211,951
156,213,123
RGD:6480464
CTD
G
BGLAP
bone gamma-carboxyglutamate (gla) protein
multiple interactions
EXP
1
156,211,951
156,213,123
RGD:6480464
CTD
G
BGLAP
bone gamma-carboxyglutamate (gla) protein
multiple interactions
ISO
1
156,211,951
156,213,123
RGD:6480464
CTD
G
BHLHE40
basic helix-loop-helix family, member e40
decreases expression
EXP
3
5,021,097
5,026,866
RGD:6480464
CTD
G
BHLHE40
basic helix-loop-helix family, member e40
increases expression
ISO
3
5,021,097
5,026,866
RGD:6480464
CTD
G
BICD1
bicaudal D homolog 1 (Drosophila)
increases expression
EXP
12
32,260,185
32,531,141
RGD:6480464
CTD
G
BID
BH3 interacting domain death agonist
multiple interactions
EXP
22
18,216,906
18,257,431
RGD:6480464
CTD
G
BID
BH3 interacting domain death agonist
multiple interactions
EXP
22
18,216,906
18,257,431
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
increases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BMP4
bone morphogenetic protein 4
increases expression
ISO
14
54,416,454
54,423,554
RGD:6480464
CTD
G
BNIP1
BCL2/adenovirus E1B 19kDa interacting protein 1
increases expression
EXP
5
172,571,445
172,591,390
RGD:6480464
CTD
G
BRCA1
breast cancer 1, early onset
increases expression
EXP
17
41,196,312
41,277,500
RGD:6480464
CTD
G
BRCA1
breast cancer 1, early onset
increases expression
EXP
17
41,196,312
41,277,500
RGD:6480464
CTD
G
BRCA1
breast cancer 1, early onset
multiple interactions
EXP
17
41,196,312
41,277,500
RGD:6480464
CTD
G
BRCA2
breast cancer 2, early onset
increases expression
EXP
13
32,889,617
32,973,809
RGD:6480464
CTD
G
BRCA2
breast cancer 2, early onset
multiple interactions
EXP
13
32,889,617
32,973,809
RGD:6480464
CTD
G
BRE
brain and reproductive organ-expressed (TNFRSF1A modulator)
increases expression
ISO
2
28,113,482
28,561,768
RGD:6480464
CTD
G
BRK1
BRICK1, SCAR/WAVE actin-nucleating complex subunit
increases expression
EXP
3
10,157,333
10,168,874
RGD:6480464
CTD
G
BSG
basigin (Ok blood group)
increases expression
ISO
19
571,277
583,493
RGD:6480464
CTD
G
BTF3
basic transcription factor 3
increases expression
ISO
5
72,794,250
72,801,448
RGD:6480464
CTD
G
BTG1
B-cell translocation gene 1, anti-proliferative
decreases expression
EXP
12
92,534,054
92,539,673
RGD:6480464
CTD
G
BTG2
BTG family, member 2
decreases expression
EXP
1
203,274,664
203,278,730
RGD:6480464
CTD
G
BTG3
BTG family, member 3
decreases methylation
EXP
21
18,965,968
18,985,268
RGD:6480464
CTD
G
BTG3
BTG family, member 3
increases expression
EXP
21
18,965,968
18,985,268
RGD:6480464
CTD
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
affects expression
EXP
2
111,395,409
111,435,684
RGD:6480464
CTD
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
increases expression
EXP
15
40,453,210
40,513,337
RGD:6480464
CTD
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
affects expression
EXP
15
40,453,210
40,513,337
RGD:6480464
CTD
G
C1QA
complement component 1, q subcomponent, A chain
increases expression
ISO
1
22,963,118
22,966,175
RGD:6480464
CTD
G
C21orf30
chromosome 21 open reading frame 30
decreases expression
ISO
RGD:6480464
CTD
G
C22orf29
chromosome 22 open reading frame 29
increases expression
EXP
22
19,833,661
19,842,371
RGD:6480464
CTD
G
C3
complement component 3
increases expression
ISO
19
6,677,846
6,720,662
RGD:6480464
CTD
G
C3
complement component 3
increases expression
ISO
19
6,677,846
6,720,662
RGD:6480464
CTD
G
C3
complement component 3
multiple interactions
ISO
19
6,677,846
6,720,662
RGD:6480464
CTD
G
C6orf48
chromosome 6 open reading frame 48
decreases expression
EXP
6
31,802,693
31,807,541
RGD:6480464
CTD
G
CA12
carbonic anhydrase XII
increases expression
EXP
15
63,615,730
63,674,075
RGD:6480464
CTD
G
CA2
carbonic anhydrase II
increases expression
EXP
8
86,376,131
86,393,721
RGD:6480464
CTD
G
CABLES1
Cdk5 and Abl enzyme substrate 1
increases expression
EXP
18
20,714,528
20,840,434
RGD:6480464
CTD
G
CAMK2N1
calcium/calmodulin-dependent protein kinase II inhibitor 1
decreases expression
EXP
1
20,808,884
20,812,728
RGD:6480464
CTD
G
CAMKK2
calcium/calmodulin-dependent protein kinase kinase 2, beta
decreases expression
EXP
12
121,675,495
121,736,111
RGD:6480464
CTD
G
CCND1
cyclin D1
increases expression
EXP
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
multiple interactions
EXP
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
decreases expression
ISO
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
multiple interactions
ISO
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CD14
CD14 molecule
increases expression
ISO
5
140,011,313
140,013,286
RGD:6480464
CTD
G
CD24
CD24 molecule
increases expression
ISO
RGD:6480464
CTD
G
CD44
CD44 molecule (Indian blood group)
decreases expression
EXP
11
35,160,417
35,253,949
RGD:6480464
CTD
G
CD58
CD58 molecule
increases expression
EXP
1
117,057,156
117,113,715
RGD:6480464
CTD
G
CD68
CD68 molecule
increases expression
ISO
17
7,482,805
7,485,429
RGD:6480464
CTD
G
CD82
CD82 molecule
increases expression
EXP
11
44,587,141
44,641,339
RGD:6480464
CTD
G
CD9
CD9 molecule
increases expression
ISO
12
6,309,482
6,347,437
RGD:6480464
CTD
G
CD97
CD97 molecule
decreases expression
EXP
19
14,491,956
14,519,537
RGD:6480464
CTD
G
CDC20
cell division cycle 20
affects expression
EXP
1
43,824,626
43,828,874
RGD:6480464
CTD
G
CDC20
cell division cycle 20
increases expression
EXP
1
43,824,626
43,828,874
RGD:6480464
CTD
G
CDC25B
cell division cycle 25B
decreases expression
EXP
20
3,776,401
3,786,762
RGD:6480464
CTD
G
CDC25C
cell division cycle 25C
decreases expression
EXP
5
137,620,959
137,667,516
RGD:6480464
CTD
G
CDC45
cell division cycle 45
increases expression
EXP
22
19,467,414
19,508,135
RGD:6480464
CTD
G
CDC6
cell division cycle 6
increases expression
EXP
17
38,444,146
38,459,413
RGD:6480464
CTD
G
CDCA5
cell division cycle associated 5
affects expression
EXP
11
64,844,927
64,851,615
RGD:6480464
CTD
G
CDCP1
CUB domain containing protein 1
increases expression
ISO
3
45,123,769
45,187,914
RGD:6480464
CTD
G
CDH1
cadherin 1, type 1, E-cadherin (epithelial)
increases expression
ISO
16
68,771,195
68,869,444
RGD:6480464
CTD
G
CDH2
cadherin 2, type 1, N-cadherin (neuronal)
increases expression
EXP
18
25,530,930
25,757,445
RGD:6480464
CTD
G
CDH22
cadherin 22, type 2
decreases expression
ISO
20
44,802,376
44,880,334
RGD:6480464
CTD
G
CDK1
cyclin-dependent kinase 1
affects expression
EXP
10
62,538,089
62,554,610
RGD:6480464
CTD
G
CDK1
cyclin-dependent kinase 1
decreases phosphorylation
EXP
10
62,538,089
62,554,610
RGD:6480464
CTD
G
CDK1
cyclin-dependent kinase 1
multiple interactions
EXP
10
62,538,089
62,554,610
RGD:6480464
CTD
G
CDK1
cyclin-dependent kinase 1
increases expression
EXP
10
62,538,089
62,554,610
RGD:6480464
CTD
G
CDK2
cyclin-dependent kinase 2
increases expression
EXP
12
56,360,556
56,366,568
RGD:6480464
CTD
G
CDK2AP2
cyclin-dependent kinase 2 associated protein 2
decreases expression
EXP
11
67,273,968
67,276,102
RGD:6480464
CTD
G
CDK5
cyclin-dependent kinase 5
increases expression
EXP
7
150,750,899
150,755,052
RGD:6480464
CTD
G
CDK8
cyclin-dependent kinase 8
increases expression
EXP
13
26,828,756
26,978,569
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
multiple interactions
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
multiple interactions
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
decreases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
decreases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
increases expression
EXP
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CDKN2C
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
decreases expression
EXP
1
51,434,367
51,440,309
RGD:6480464
CTD
G
CDKN3
cyclin-dependent kinase inhibitor 3
decreases expression
EXP
14
54,863,673
54,886,936
RGD:6480464
CTD
G
CDT1
chromatin licensing and DNA replication factor 1
increases expression
EXP
16
88,870,186
88,875,666
RGD:6480464
CTD
G
CEACAM1
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
increases expression
ISO
19
43,011,458
43,032,661
RGD:6480464
CTD
G
CEACAM1
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
increases expression
ISO
19
43,011,458
43,032,661
RGD:6480464
CTD
G
CEBPB
CCAAT/enhancer binding protein (C/EBP), beta
increases expression
EXP
20
48,807,120
48,809,227
RGD:6480464
CTD
G
CEBPB
CCAAT/enhancer binding protein (C/EBP), beta
decreases expression
ISO
20
48,807,120
48,809,227
RGD:6480464
CTD
G
CEBPB
CCAAT/enhancer binding protein (C/EBP), beta
increases expression
ISO
20
48,807,120
48,809,227
RGD:6480464
CTD
G
CEBPD
CCAAT/enhancer binding protein (C/EBP), delta
decreases expression
EXP
8
48,649,476
48,650,726
RGD:6480464
CTD
G
CEBPD
CCAAT/enhancer binding protein (C/EBP), delta
increases expression
EXP
8
48,649,476
48,650,726
RGD:6480464
CTD
G
CENPA
centromere protein A
increases expression
EXP
2
27,008,882
27,017,457
RGD:6480464
CTD
G
CENPE
centromere protein E, 312kDa
affects expression
EXP
4
104,026,963
104,119,566
RGD:6480464
CTD
G
CENPF
centromere protein F, 350/400kDa
affects expression
EXP
1
214,776,532
214,837,914
RGD:6480464
CTD
G
CENPF
centromere protein F, 350/400kDa
increases expression
EXP
1
214,776,532
214,837,914
RGD:6480464
CTD
G
CENPJ
centromere protein J
increases expression
EXP
13
25,456,412
25,497,027
RGD:6480464
CTD
G
CENPN
centromere protein N
increases expression
EXP
16
81,040,103
81,066,712
RGD:6480464
CTD
G
CFI
complement factor I
increases expression
ISO
4
110,661,848
110,723,335
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
affects localization
EXP
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
increases activity
EXP
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
multiple interactions
EXP
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
increases activity
EXP
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
multiple interactions
ISO
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
increases activity
ISO
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
multiple interactions
ISO
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CFTR
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
increases expression
ISO
7
117,120,017
117,308,719
RGD:6480464
CTD
G
CHAC2
ChaC, cation transport regulator homolog 2 (E. coli)
increases expression
EXP
2
53,994,929
54,002,287
RGD:6480464
CTD
G
CHAF1A
chromatin assembly factor 1, subunit A (p150)
decreases expression
EXP
19
4,402,660
4,443,394
RGD:6480464
CTD
G
CHEK1
checkpoint kinase 1
increases expression
EXP
11
125,495,031
125,546,150
RGD:6480464
CTD
G
CHSY1
chondroitin sulfate synthase 1
increases expression
EXP
15
101,715,928
101,792,137
RGD:6480464
CTD
G
CILP
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase
increases expression
EXP
15
65,488,337
65,503,840
RGD:6480464
CTD
G
CISH
cytokine inducible SH2-containing protein
multiple interactions
ISO
3
50,643,885
50,649,262
RGD:6480464
CTD
G
CIT
citron (rho-interacting, serine/threonine kinase 21)
affects expression
EXP
12
120,123,595
120,315,095
RGD:6480464
CTD
G
CITED2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
EXP
6
139,693,392
139,695,787
RGD:6480464
CTD
G
CKB
creatine kinase, brain
increases activity
EXP
14
103,985,995
103,989,196
RGD:6480464
CTD
G
CKB
creatine kinase, brain
multiple interactions
EXP
14
103,985,995
103,989,196
RGD:6480464
CTD
G
CKB
creatine kinase, brain
increases expression
ISO
14
103,985,995
103,989,196
RGD:6480464
CTD
G
CKMT1B
creatine kinase, mitochondrial 1B
increases expression
ISO
15
43,885,252
43,891,604
RGD:6480464
CTD
G
CKS1B
CDC28 protein kinase regulatory subunit 1B
increases expression
EXP
1
154,947,118
154,951,725
RGD:6480464
CTD
G
CLCA1
chloride channel accessory 1
increases expression
ISO
1
86,934,526
86,965,977
RGD:6480464
CTD
G
CLCA1
chloride channel accessory 1
increases expression
ISO
1
86,934,526
86,965,977
RGD:6480464
CTD
G
CLDN1
claudin 1
increases expression
EXP
3
190,023,490
190,040,235
RGD:6480464
CTD
G
CLDN4
claudin 4
decreases expression
EXP
7
73,245,193
73,247,015
RGD:6480464
CTD
G
CLDN5
claudin 5
decreases expression
ISO
22
19,510,547
19,512,860
RGD:6480464
CTD
G
CLDN7
claudin 7
increases expression
ISO
17
7,163,222
7,166,512
RGD:6480464
CTD
G
CLIC6
chloride intracellular channel 6
increases expression
EXP
21
36,041,688
36,090,519
RGD:6480464
CTD
G
CLNS1A
chloride channel, nucleotide-sensitive, 1A
increases expression
ISO
11
77,327,196
77,348,851
RGD:6480464
CTD
G
CLPTM1
cleft lip and palate associated transmembrane protein 1
decreases expression
EXP
19
45,457,842
45,496,604
RGD:6480464
CTD
G
CLU
clusterin
increases expression
ISO
8
27,454,434
27,472,328
RGD:6480464
CTD
G
CLU
clusterin
affects expression
ISO
8
27,454,434
27,472,328
RGD:6480464
CTD
G
CLU
clusterin
multiple interactions
ISO
8
27,454,434
27,472,328
RGD:6480464
CTD
G
CLU
clusterin
decreases expression
ISO
8
27,454,434
27,472,328
RGD:6480464
CTD
G
CNDP2
CNDP dipeptidase 2 (metallopeptidase M20 family)
increases expression
ISO
18
72,163,500
72,190,689
RGD:6480464
CTD
G
CNFN
cornifelin
decreases expression
EXP
19
42,891,171
42,894,444
RGD:6480464
CTD
G
CNTN3
contactin 3 (plasmacytoma associated)
decreases expression
ISO
3
74,311,722
74,570,343
RGD:6480464
CTD
G
COL12A1
collagen, type XII, alpha 1
increases expression
EXP
6
75,794,042
75,915,623
RGD:6480464
CTD
G
COL18A1
collagen, type XVIII, alpha 1
decreases expression
EXP
21
46,825,097
46,933,634
RGD:6480464
CTD
G
COL1A1
collagen, type I, alpha 1
multiple interactions
ISO
17
48,261,457
48,279,000
RGD:6480464
CTD
G
COL1A1
collagen, type I, alpha 1
multiple interactions
ISO
17
48,261,457
48,279,000
RGD:6480464
CTD
G
COL1A1
collagen, type I, alpha 1
decreases expression
ISO
17
48,261,457
48,279,000
RGD:6480464
CTD
G
COL1A2
collagen, type I, alpha 2
decreases expression
ISO
7
94,023,873
94,060,544
RGD:6480464
CTD
G
COL2A1
collagen, type II, alpha 1
increases expression
ISO
12
48,366,748
48,398,285
RGD:6480464
CTD
G
COL5A1
collagen, type V, alpha 1
increases expression
ISO
9
137,533,652
137,736,689
RGD:6480464
CTD
G
COL6A3
collagen, type VI, alpha 3
increases expression
ISO
2
238,232,655
238,322,850
RGD:6480464
CTD
G
COMT
catechol-O-methyltransferase
multiple interactions
EXP
22
19,929,263
19,957,498
RGD:6480464
CTD
G
COMT
catechol-O-methyltransferase
multiple interactions
EXP
22
19,929,263
19,957,498
RGD:6480464
CTD
G
COMT
catechol-O-methyltransferase
decreases expression
EXP
22
19,929,263
19,957,498
RGD:6480464
CTD
G
COMT
catechol-O-methyltransferase
decreases activity
EXP
22
19,929,263
19,957,498
RGD:6480464
CTD
G
COPS7A
COP9 signalosome subunit 7A
increases expression
ISO
12
6,833,150
6,841,041
RGD:6480464
CTD
G
COQ7
coenzyme Q7 homolog, ubiquinone (yeast)
increases expression
ISO
16
19,078,917
19,091,417
RGD:6480464
CTD
G
CP
ceruloplasmin (ferroxidase)
increases expression
ISO
3
148,880,197
148,939,832
RGD:6480464
CTD
G
CRISPLD2
cysteine-rich secretory protein LCCL domain containing 2
increases expression
ISO
16
84,853,587
84,943,116
RGD:6480464
CTD
G
CYLD
cylindromatosis (turban tumor syndrome)
increases expression
EXP
16
50,775,961
50,835,846
RGD:6480464
CTD
G
CYP17A1
cytochrome P450, family 17, subfamily A, polypeptide 1
decreases expression
ISO
10
104,590,288
104,597,290
RGD:6480464
CTD
G
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
multiple interactions
EXP
15
51,500,254
51,630,795
RGD:6480464
CTD
G
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
decreases activity
EXP
15
51,500,254
51,630,795
RGD:6480464
CTD
G
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
decreases expression
EXP
15
51,500,254
51,630,795
RGD:6480464
CTD
G
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
increases expression
EXP
15
51,500,254
51,630,795
RGD:6480464
CTD
G
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
increases activity
EXP
15
51,500,254
51,630,795
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
multiple interactions
EXP
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
multiple interactions
ISO
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
decreases expression
EXP
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
multiple interactions
EXP
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
decreases activity
EXP
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
decreases expression
EXP
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
increases expression
EXP
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A1
cytochrome P450, family 1, subfamily A, polypeptide 1
increases activity
EXP
15
75,011,883
75,017,877
RGD:6480464
CTD
G
CYP1A2
cytochrome P450, family 1, subfamily A, polypeptide 2
increases chemical synthesis
EXP
15
75,041,184
75,048,941
RGD:6480464
CTD
G
CYP1A2
cytochrome P450, family 1, subfamily A, polypeptide 2
increases hydroxylation
ISO
15
75,041,184
75,048,941
RGD:6480464
CTD
G
CYP1A2
cytochrome P450, family 1, subfamily A, polypeptide 2
increases metabolic processing
EXP
15
75,041,184
75,048,941
RGD:6480464
CTD
G
CYP1B1
cytochrome P450, family 1, subfamily B, polypeptide 1
affects chemical synthesis
EXP
2
38,294,746
38,303,323
RGD:6480464
CTD
G
CYP1B1
cytochrome P450, family 1, subfamily B, polypeptide 1
decreases activity
EXP
2
38,294,746
38,303,323
RGD:6480464
CTD
G
CYP1B1
cytochrome P450, family 1, subfamily B, polypeptide 1
decreases expression
EXP
2
38,294,746
38,303,323
RGD:6480464
CTD
G
CYP1B1
cytochrome P450, family 1, subfamily B, polypeptide 1
decreases expression
ISO
2
38,294,746
38,303,323
RGD:6480464
CTD
G
CYP1B1
cytochrome P450, family 1, subfamily B, polypeptide 1
increases expression
EXP
2
38,294,746
38,303,323
RGD:6480464
CTD
G
CYP24A1
cytochrome P450, family 24, subfamily A, polypeptide 1
multiple interactions
EXP
20
52,769,988
52,790,516
RGD:6480464
CTD
G
CYP24A1
cytochrome P450, family 24, subfamily A, polypeptide 1
decreases activity
EXP
20
52,769,988
52,790,516
RGD:6480464
CTD
G
CYP27B1
cytochrome P450, family 27, subfamily B, polypeptide 1
affects activity
EXP
12
58,156,117
58,160,976
RGD:6480464
CTD
G
CYP27B1
cytochrome P450, family 27, subfamily B, polypeptide 1
affects expression
EXP
12
58,156,117
58,160,976
RGD:6480464
CTD
G
CYP27B1
cytochrome P450, family 27, subfamily B, polypeptide 1
increases activity
EXP
12
58,156,117
58,160,976
RGD:6480464
CTD
G
CYP27B1
cytochrome P450, family 27, subfamily B, polypeptide 1
increases expression
EXP
12
58,156,117
58,160,976
RGD:6480464
CTD
G
CYP3A
cytochrome P450, subfamily IIA (niphedipine oxidase)
affects expression
ISO
RGD:6480464
CTD
G
CYP3A4
cytochrome P450, family 3, subfamily A, polypeptide 4
multiple interactions
EXP
7
99,354,583
99,381,811
RGD:6480464
CTD
G
CYP46A1
cytochrome P450, family 46, subfamily A, polypeptide 1
increases expression
EXP
14
100,150,755
100,193,638
RGD:6480464
CTD
G
CYP4B1
cytochrome P450, family 4, subfamily B, polypeptide 1
decreases expression
EXP
1
47,264,670
47,285,021
RGD:6480464
CTD
G
CYTH1
cytohesin 1
decreases expression
EXP
17
76,670,130
76,778,376
RGD:6480464
CTD
G
CYTH1
cytohesin 1
increases expression
ISO
17
76,670,130
76,778,376
RGD:6480464
CTD
G
CYTH3
cytohesin 3
decreases expression
EXP
7
6,201,410
6,312,242
RGD:6480464
CTD
G
DAD1
defender against cell death 1
increases expression
EXP
14
23,033,807
23,058,143
RGD:6480464
CTD
G
DBNDD2
dysbindin (dystrobrevin binding protein 1) domain containing 2
decreases expression
EXP
20
44,034,633
44,039,250
RGD:6480464
CTD
G
DCT
dopachrome tautomerase
decreases expression
EXP
13
95,091,835
95,131,936
RGD:6480464
CTD
G
DCXR
dicarbonyl/L-xylulose reductase
increases expression
EXP
17
79,993,757
79,995,573
RGD:6480464
CTD
G
DDC
dopa decarboxylase (aromatic L-amino acid decarboxylase)
increases expression
EXP
7
50,526,134
50,633,154
RGD:6480464
CTD
G
DDIT3
DNA-damage-inducible transcript 3
increases expression
EXP
12
57,910,371
57,914,300
RGD:6480464
CTD
G
DDIT4
DNA-damage-inducible transcript 4
increases expression
ISO
10
74,033,677
74,035,797
RGD:6480464
CTD
G
DEPDC1B
DEP domain containing 1B
increases expression
EXP
5
59,892,739
59,995,993
RGD:6480464
CTD
G
DFFB
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
increases expression
EXP
1
3,773,845
3,801,993
RGD:6480464
CTD
G
DHCR24
24-dehydrocholesterol reductase
decreases expression
EXP
1
55,315,300
55,352,921
RGD:6480464
CTD
G
DHFRL1
dihydrofolate reductase-like 1
increases expression
EXP
3
93,776,766
93,782,067
RGD:6480464
CTD
G
DHRS2
dehydrogenase/reductase (SDR family) member 2
increases expression
EXP
14
24,105,573
24,114,848
RGD:6480464
CTD
G
DHRS3
dehydrogenase/reductase (SDR family) member 3
increases expression
EXP
1
12,627,939
12,677,820
RGD:6480464
CTD
G
DLGAP5
discs, large (Drosophila) homolog-associated protein 5
affects expression
EXP
14
55,614,834
55,658,396
RGD:6480464
CTD
G
DLK1
delta-like 1 homolog (Drosophila)
increases expression
ISO
14
101,193,202
101,201,467
RGD:6480464
CTD
G
DLX5
distal-less homeobox 5
decreases expression
ISO
7
96,649,702
96,654,143
RGD:6480464
CTD
G
DNAJB9
DnaJ (Hsp40) homolog, subfamily B, member 9
increases expression
EXP
7
108,210,189
108,215,294
RGD:6480464
CTD
G
DNAJC17
DnaJ (Hsp40) homolog, subfamily C, member 17
decreases expression
EXP
15
41,060,067
41,099,676
RGD:6480464
CTD
G
DNAJC21
DnaJ (Hsp40) homolog, subfamily C, member 21
increases expression
EXP
5
34,929,698
34,959,069
RGD:6480464
CTD
G
DNMT1
DNA (cytosine-5-)-methyltransferase 1
decreases expression
EXP
19
10,244,022
10,305,755
RGD:6480464
CTD
G
DNMT1
DNA (cytosine-5-)-methyltransferase 1
decreases expression
EXP
19
10,244,022
10,305,755
RGD:6480464
CTD
G
DNMT3B
DNA (cytosine-5-)-methyltransferase 3 beta
decreases expression
EXP
20
31,350,191
31,397,162
RGD:6480464
CTD
G
DOCK3
dedicator of cytokinesis 3
multiple interactions
EXP
3
50,712,672
51,421,629
RGD:6480464
CTD
G
DOK4
docking protein 4
increases expression
EXP
16
57,505,870
57,520,385
RGD:6480464
CTD
G
DRG2
developmentally regulated GTP binding protein 2
decreases expression
EXP
17
17,991,181
18,011,299
RGD:6480464
CTD
G
DRG2
developmentally regulated GTP binding protein 2
increases expression
EXP
17
17,991,181
18,011,299
RGD:6480464
CTD
G
DSTN
destrin (actin depolymerizing factor)
increases expression
ISO
20
17,550,599
17,588,652
RGD:6480464
CTD
G
DTL
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
increases expression
EXP
1
212,208,919
212,278,187
RGD:6480464
CTD
G
DTYMK
deoxythymidylate kinase (thymidylate kinase)
increases expression
EXP
2
242,615,157
242,626,383
RGD:6480464
CTD
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
5
172,195,093
172,198,203
RGD:6480464
CTD
G
DUSP4
dual specificity phosphatase 4
decreases expression
EXP
8
29,190,579
29,208,267
RGD:6480464
CTD
G
E2F2
E2F transcription factor 2
decreases expression
EXP
1
23,832,920
23,857,712
RGD:6480464
CTD
G
EBAG9
estrogen receptor binding site associated, antigen, 9
increases expression
EXP
8
110,551,929
110,577,392
RGD:6480464
CTD
G
EBP
emopamil binding protein (sterol isomerase)
increases expression
EXP
X
48,380,164
48,387,104
RGD:6480464
CTD
G
ECH1
enoyl CoA hydratase 1, peroxisomal
decreases expression
EXP
19
39,306,062
39,322,497
RGD:6480464
CTD
G
ECT2
epithelial cell transforming sequence 2 oncogene
increases expression
EXP
3
172,468,475
172,539,264
RGD:6480464
CTD
G
EDC4
enhancer of mRNA decapping 4
decreases expression
EXP
16
67,906,926
67,918,417
RGD:6480464
CTD
G
EEF2
eukaryotic translation elongation factor 2
decreases expression
EXP
19
3,976,054
3,985,461
RGD:6480464
CTD
G
EFNB2
ephrin-B2
decreases expression
EXP
13
107,142,079
107,187,388
RGD:6480464
CTD
G
EGF
epidermal growth factor
multiple interactions
EXP
4
110,834,040
110,934,118
RGD:6480464
CTD
G
EGFR
epidermal growth factor receptor
multiple interactions
EXP
7
55,086,725
55,275,031
RGD:6480464
CTD
G
EGFR
epidermal growth factor receptor
decreases expression
EXP
7
55,086,725
55,275,031
RGD:6480464
CTD
G
EGFR
epidermal growth factor receptor
decreases expression
ISO
7
55,086,725
55,275,031
RGD:6480464
CTD
G
EGFR
epidermal growth factor receptor
increases expression
ISO
7
55,086,725
55,275,031
RGD:6480464
CTD
G
EGR1
early growth response 1
increases expression
EXP
5
137,801,181
137,805,004
RGD:6480464
CTD
G
EGR1
early growth response 1
increases expression
ISO
5
137,801,181
137,805,004
RGD:6480464
CTD
G
EGR3
early growth response 3
increases expression
EXP
8
22,545,174
22,550,815
RGD:6480464
CTD
G
EIF2AK2
eukaryotic translation initiation factor 2-alpha kinase 2
increases expression
ISO
2
37,332,281
37,384,190
RGD:6480464
CTD
G
EIF5A
eukaryotic translation initiation factor 5A
decreases expression
EXP
17
7,210,318
7,215,782
RGD:6480464
CTD
G
ELF3
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
increases expression
ISO
1
201,979,690
201,986,316
RGD:6480464
CTD
G
ELOVL5
ELOVL fatty acid elongase 5
decreases expression
EXP
6
53,132,196
53,213,977
RGD:6480464
CTD
G
EMP2
epithelial membrane protein 2
increases expression
EXP
16
10,622,279
10,674,539
RGD:6480464
CTD
G
ENO1
enolase 1, (alpha)
increases expression
ISO
1
8,921,059
8,939,151
RGD:6480464
CTD
G
ENO1
enolase 1, (alpha)
increases expression
ISO
1
8,921,059
8,939,151
RGD:6480464
CTD
G
ENO2
enolase 2 (gamma, neuronal)
decreases expression
EXP
12
7,023,614
7,032,859
RGD:6480464
CTD
G
ENO3
enolase 3 (beta, muscle)
decreases expression
EXP
17
4,854,384
4,860,426
RGD:6480464
CTD
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
decreases expression
EXP
8
120,569,317
120,651,106
RGD:6480464
CTD
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
decreases expression
ISO
8
120,569,317
120,651,106
RGD:6480464
CTD
G
EPB41L2
erythrocyte membrane protein band 4.1-like 2
increases expression
EXP
6
131,160,487
131,384,462
RGD:6480464
CTD
G
EPCAM
epithelial cell adhesion molecule
increases expression
ISO
2
47,596,287
47,614,167
RGD:6480464
CTD
G
EPHA1
EPH receptor A1
multiple interactions
EXP
7
143,088,205
143,105,985
RGD:6480464
CTD
G
EPHA8
EPH receptor A8
increases expression
ISO
1
22,890,004
22,930,087
RGD:6480464
CTD
G
EPHB4
EPH receptor B4
decreases expression
EXP
7
100,400,187
100,425,143
RGD:6480464
CTD
G
ESR1
estrogen receptor 1
affects response to substance
ISO
6
152,011,631
152,424,409
RGD:6480464
CTD
G
ESR1
estrogen receptor 1
decreases expression
ISO
6
152,011,631
152,424,409
RGD:6480464
CTD
G
ESR1
estrogen receptor 1
increases activity
ISO
6
152,011,631
152,424,409
RGD:6480464
CTD
G
ESR1
estrogen receptor 1
increases phosphorylation
ISO
6
152,011,631
152,424,409
RGD:6480464
CTD
G
ESR1
estrogen receptor 1
increases expression
ISO
6
152,011,631
152,424,409
RGD:6480464
CTD
G
ESR1
estrogen receptor 1
multiple interactions
ISO
6
152,011,631
152,424,409
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
affects response to substance
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
affects binding
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
affects binding
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
decreases expression
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases activity
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases activity
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases expression
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases expression
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases expression
EXP
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases activity
ISO
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
affects binding
ISO
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases expression
ISO
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
ISO
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
ISO
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
multiple interactions
ISO
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESR2
estrogen receptor 2 (ER beta)
increases expression
ISO
14
64,693,751
64,805,268
RGD:6480464
CTD
G
ESRRA
estrogen-related receptor alpha
multiple interactions
EXP
11
64,073,044
64,084,210
RGD:6480464
CTD
G
ESRRA
estrogen-related receptor alpha
multiple interactions
EXP
11
64,073,044
64,084,210
RGD:6480464
CTD
G
ESRRB
estrogen-related receptor beta
multiple interactions
EXP
14
76,837,690
76,968,180
RGD:6480464
CTD
G
ESRRG
estrogen-related receptor gamma
multiple interactions
EXP
1
216,676,588
217,311,097
RGD:6480464
CTD
G
ETNK2
ethanolamine kinase 2
increases expression
EXP
1
204,100,190
204,121,307
RGD:6480464
CTD
G
ETS2
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)
decreases expression
EXP
21
40,177,231
40,196,879
RGD:6480464
CTD
G
EXTL3
exostosin-like glycosyltransferase 3
decreases expression
EXP
8
28,559,153
28,611,202
RGD:6480464
CTD
G
EZR
ezrin
increases expression
ISO
6
159,186,773
159,240,456
RGD:6480464
CTD
G
FABP3
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)
increases expression
ISO
1
31,838,100
31,845,923
RGD:6480464
CTD
G
FAM107A
family with sequence similarity 107, member A
decreases expression
EXP
3
58,549,844
58,563,491
RGD:6480464
CTD
G
FAM122A
family with sequence similarity 122A
increases expression
EXP
9
71,394,964
71,398,609
RGD:6480464
CTD
G
FAM168A
family with sequence similarity 168, member A
decreases expression
EXP
11
73,117,028
73,309,228
RGD:6480464
CTD
G
FAM20C
family with sequence similarity 20, member C
increases expression
ISO
7
192,969
300,740
RGD:6480464
CTD
G
FAM3D
family with sequence similarity 3, member D
increases expression
ISO
3
58,619,670
58,652,561
RGD:6480464
CTD
G
FANCC
Fanconi anemia, complementation group C
decreases expression
EXP
9
97,861,336
98,079,991
RGD:6480464
CTD
G
FANCI
Fanconi anemia, complementation group I
increases expression
EXP
15
89,787,194
89,860,362
RGD:6480464
CTD
G
FAS
Fas (TNF receptor superfamily, member 6)
decreases expression
ISO
10
90,750,288
90,775,542
RGD:6480464
CTD
G
FAT1
FAT tumor suppressor homolog 1 (Drosophila)
decreases expression
ISO
4
187,508,937
187,644,987
RGD:6480464
CTD
G
FBXO32
F-box protein 32
increases expression
EXP
8
124,510,127
124,553,493
RGD:6480464
CTD
G
FBXO5
F-box protein 5
increases expression
EXP
6
153,291,658
153,304,740
RGD:6480464
CTD
G
FCGBP
Fc fragment of IgG binding protein
increases expression
ISO
19
40,353,963
40,440,533
RGD:6480464
CTD
G
FCGBP
Fc fragment of IgG binding protein
increases expression
ISO
19
40,353,963
40,440,533
RGD:6480464
CTD
G
FEN1
flap structure-specific endonuclease 1
increases expression
EXP
11
61,560,109
61,564,716
RGD:6480464
CTD
G
FETUB
fetuin B
decreases expression
ISO
3
186,358,149
186,370,797
RGD:6480464
CTD
G
FHL1
four and a half LIM domains 1
multiple interactions
ISO
X
135,228,861
135,293,518
RGD:6480464
CTD
G
FKBP4
FK506 binding protein 4, 59kDa
increases expression
EXP
12
2,904,108
2,914,589
RGD:6480464
CTD
G
FMN2
formin 2
multiple interactions
EXP
1
240,255,185
240,638,489
RGD:6480464
CTD
G
FNDC5
fibronectin type III domain containing 5
decreases expression
EXP
1
33,327,869
33,338,082
RGD:6480464
CTD
G
FOLR1
folate receptor 1 (adult)
decreases expression
EXP
11
71,900,602
71,907,367
RGD:6480464
CTD
G
FOS
FBJ murine osteosarcoma viral oncogene homolog
multiple interactions
EXP
14
75,745,481
75,748,937
RGD:6480464
CTD
G
FOS
FBJ murine osteosarcoma viral oncogene homolog
increases expression
EXP
14
75,745,481
75,748,937
RGD:6480464
CTD
G
FOS
FBJ murine osteosarcoma viral oncogene homolog
increases expression
ISO
14
75,745,481
75,748,937
RGD:6480464
CTD
G
FOXD1
forkhead box D1
increases expression
EXP
5
72,742,083
72,744,352
RGD:6480464
CTD
G
FOXJ1
forkhead box J1
decreases expression
EXP
17
74,132,414
74,137,380
RGD:6480464
CTD
G
FOXO3
forkhead box O3
affects expression
EXP
6
108,881,026
109,005,971
RGD:6480464
CTD
G
FOXO3
forkhead box O3
affects localization
EXP
6
108,881,026
109,005,971
RGD:6480464
CTD
G
FOXO3
forkhead box O3
multiple interactions
EXP
6
108,881,026
109,005,971
RGD:6480464
CTD
G
FOXO3
forkhead box O3
decreases phosphorylation
EXP
6
108,881,026
109,005,971
RGD:6480464
CTD
G
FUT2
fucosyltransferase 2 (secretor status included)
increases expression
ISO
19
49,199,228
49,209,191
RGD:6480464
CTD
G
FXYD3
FXYD domain containing ion transport regulator 3
increases expression
ISO
19
35,606,732
35,615,228
RGD:6480464
CTD
G
FZD1
frizzled family receptor 1
decreases expression
ISO
7
90,893,783
90,898,132
RGD:6480464
CTD
G
FZD3
frizzled family receptor 3
increases expression
EXP
8
28,351,722
28,431,785
RGD:6480464
CTD
G
G0S2
G0/G1switch 2
increases expression
EXP
1
209,848,670
209,849,735
RGD:6480464
CTD
G
GAA
glucosidase, alpha; acid
increases expression
EXP
17
78,075,355
78,093,679
RGD:6480464
CTD
G
GADD45A
growth arrest and DNA-damage-inducible, alpha
decreases expression
EXP
1
68,150,860
68,154,021
RGD:6480464
CTD
G
GADD45A
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
1
68,150,860
68,154,021
RGD:6480464
CTD
G
GADD45A
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
1
68,150,860
68,154,021
RGD:6480464
CTD
G
GALNT4
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4)
increases expression
EXP
12
89,913,189
89,918,583
RGD:6480464
CTD
G
GALR2
galanin receptor 2
decreases expression
EXP
17
74,070,892
74,073,573
RGD:6480464
CTD
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
12
6,643,585
6,647,537
RGD:6480464
CTD
G
GAS6
growth arrest-specific 6
increases expression
ISO
13
114,523,522
114,567,046
RGD:6480464
CTD
G
GBP1
guanylate binding protein 1, interferon-inducible
decreases expression
EXP
1
89,517,987
89,531,043
RGD:6480464
CTD
G
GBP2
guanylate binding protein 2, interferon-inducible
increases expression
ISO
1
89,573,310
89,591,799
RGD:6480464
CTD
G
GCLM
glutamate-cysteine ligase, modifier subunit
decreases expression
ISO
1
94,352,590
94,375,012
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
increases expression
ISO
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDPD5
glycerophosphodiester phosphodiesterase domain containing 5
increases expression
EXP
11
75,145,685
75,236,599
RGD:6480464
CTD
G
GFRA1
GDNF family receptor alpha 1
increases expression
EXP
10
117,816,436
118,033,126
RGD:6480464
CTD
G
GGH
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
increases expression
EXP
8
63,927,638
63,951,610
RGD:6480464
CTD
G
GHR
growth hormone receptor
increases expression
ISO
5
42,423,877
42,721,980
RGD:6480464
CTD
G
GHRH
growth hormone releasing hormone
increases expression
ISO
20
35,879,489
35,885,299
RGD:6480464
CTD
G
GINS1
GINS complex subunit 1 (Psf1 homolog)
increases expression
EXP
20
25,388,323
25,429,191
RGD:6480464
CTD
G
GINS2
GINS complex subunit 2 (Psf2 homolog)
increases expression
EXP
16
85,711,280
85,722,588
RGD:6480464
CTD
G
GJA1
gap junction protein, alpha 1, 43kDa
increases expression
ISO
6
121,756,745
121,770,873
RGD:6480464
CTD
G
GJB2
gap junction protein, beta 2, 26kDa
increases expression
ISO
13
20,761,602
20,767,114
RGD:6480464
CTD
G
GLB1
galactosidase, beta 1
increases expression
ISO
3
33,038,100
33,138,694
RGD:6480464
CTD
G
GLI1
GLI family zinc finger 1
decreases expression
ISO
12
57,853,918
57,866,051
RGD:6480464
CTD
G
GLRA1
glycine receptor, alpha 1
decreases activity
EXP
5
151,202,074
151,304,397
RGD:6480464
CTD
G
GLRA1
glycine receptor, alpha 1
multiple interactions
EXP
5
151,202,074
151,304,397
RGD:6480464
CTD
G
HBG1
hemoglobin, gamma A
decreases expression
ISO
11
5,269,502
5,271,087
RGD:6480464
CTD
G
HIST3H3
histone cluster 3, H3
multiple interactions
EXP
1
228,612,546
228,613,026
RGD:6480464
CTD
G
HIST3H3
histone cluster 3, H3
increases expression
EXP
1
228,612,546
228,613,026
RGD:6480464
CTD
G
HIVEP1
human immunodeficiency virus type I enhancer binding protein 1
increases expression
EXP
6
12,012,724
12,165,232
RGD:6480464
CTD
G
HM13
histocompatibility (minor) 13
decreases expression
EXP
20
30,102,241
30,157,370
RGD:6480464
CTD
G
HMGB2
high mobility group box 2
increases expression
EXP
4
174,252,527
174,255,595
RGD:6480464
CTD
G
HMGB2
high mobility group box 2
decreases expression
ISO
4
174,252,527
174,255,595
RGD:6480464
CTD
G
HMGCS2
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)
increases expression
ISO
1
120,290,619
120,311,555
RGD:6480464
CTD
G
HMGN2
high mobility group nucleosomal binding domain 2
decreases expression
EXP
1
26,798,902
26,803,133
RGD:6480464
CTD
G
HMOX1
heme oxygenase (decycling) 1
multiple interactions
ISO
22
35,777,060
35,790,207
RGD:6480464
CTD
G
HOMER2
homer homolog 2 (Drosophila)
decreases expression
EXP
15
83,517,729
83,621,476
RGD:6480464
CTD
G
HOXA10
homeobox A10
increases expression
EXP
7
27,210,210
27,219,880
RGD:6480464
CTD
G
HOXA10
homeobox A10
decreases expression
ISO
7
27,210,210
27,219,880
RGD:6480464
CTD
G
HOXA10
homeobox A10
increases expression
ISO
7
27,210,210
27,219,880
RGD:6480464
CTD
G
HOXA11
homeobox A11
decreases expression
ISO
7
27,220,776
27,224,835
RGD:6480464
CTD
G
HOXA4
homeobox A4
increases expression
ISO
7
27,168,126
27,170,399
RGD:6480464
CTD
G
HOXB6
homeobox B6
increases expression
ISO
17
46,673,099
46,682,334
RGD:6480464
CTD
G
HOXD8
homeobox D8
decreases expression
ISO
2
176,994,422
176,997,423
RGD:6480464
CTD
G
HSD11B2
hydroxysteroid (11-beta) dehydrogenase 2
increases expression
ISO
16
67,465,036
67,471,456
RGD:6480464
CTD
G
HSD17B1
hydroxysteroid (17-beta) dehydrogenase 1
decreases activity
EXP
17
40,703,984
40,707,232
RGD:6480464
CTD
G
HSD17B11
hydroxysteroid (17-beta) dehydrogenase 11
increases expression
ISO
4
88,257,691
88,312,455
RGD:6480464
CTD
G
HSP90AA1
heat shock protein 90kDa alpha (cytosolic), class A member 1
increases expression
ISO
14
102,547,075
102,606,086
RGD:6480464
CTD
G
HSPA1A
heat shock 70kDa protein 1A
increases expression
ISO
6
31,783,291
31,785,719
RGD:6480464
CTD
G
HSPA1B
heat shock 70kDa protein 1B
increases expression
ISO
6
31,795,512
31,798,031
RGD:6480464
CTD
G
HSPA4L
heat shock 70kDa protein 4-like
increases expression
EXP
4
128,703,453
128,754,522
RGD:6480464
CTD
G
HSPH1
heat shock 105kDa/110kDa protein 1
increases expression
ISO
13
31,710,762
31,736,117
RGD:6480464
CTD
G
HYI
hydroxypyruvate isomerase (putative)
decreases expression
EXP
1
43,916,674
43,919,660
RGD:6480464
CTD
G
ID3
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
decreases expression
EXP
1
23,884,421
23,886,285
RGD:6480464
CTD
G
IDI1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
10
1,085,963
1,095,061
RGD:6480464
CTD
G
IER3
immediate early response 3
increases expression
ISO
6
30,710,976
30,712,327
RGD:6480464
CTD
G
IFIT1
interferon-induced protein with tetratricopeptide repeats 1
increases expression
ISO
10
91,152,303
91,166,244
RGD:6480464
CTD
G
IFIT3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
10
91,087,602
91,100,725
RGD:6480464
CTD
G
IFIT3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
10
91,087,602
91,100,725
RGD:6480464
CTD
G
IFITM3
interferon induced transmembrane protein 3
decreases expression
EXP
11
319,673
320,914
RGD:6480464
CTD
G
IFNG
interferon, gamma
multiple interactions
EXP
12
68,548,550
68,553,521
RGD:6480464
CTD
G
IFNG
interferon, gamma
affects expression
ISO
12
68,548,550
68,553,521
RGD:6480464
CTD
G
IFNG
interferon, gamma
multiple interactions
ISO
12
68,548,550
68,553,521
RGD:6480464
CTD
G
IFNG
interferon, gamma
decreases secretion
ISO
12
68,548,550
68,553,521
RGD:6480464
CTD
G
IFNG
interferon, gamma
multiple interactions
ISO
12
68,548,550
68,553,521
RGD:6480464
CTD
G
IFRD2
interferon-related developmental regulator 2
multiple interactions
EXP
3
50,325,163
50,330,026
RGD:6480464
CTD
G
IGF1
insulin-like growth factor 1 (somatomedin C)
decreases expression
ISO
12
102,789,645
102,874,378
RGD:6480464
CTD
G
IGF1
insulin-like growth factor 1 (somatomedin C)
increases expression
ISO
12
102,789,645
102,874,378
RGD:6480464
CTD
G
IGF1
insulin-like growth factor 1 (somatomedin C)
affects activity
ISO
12
102,789,645
102,874,378
RGD:6480464
CTD
G
IGF1
insulin-like growth factor 1 (somatomedin C)
increases expression
ISO
12
102,789,645
102,874,378
RGD:6480464
CTD
G
IGF1R
insulin-like growth factor 1 receptor
decreases expression
EXP
15
99,192,761
99,507,759
RGD:6480464
CTD
G
IGF1R
insulin-like growth factor 1 receptor
multiple interactions
ISO
15
99,192,761
99,507,759
RGD:6480464
CTD
G
IGF1R
insulin-like growth factor 1 receptor
multiple interactions
ISO
15
99,192,761
99,507,759
RGD:6480464
CTD
G
IGF1R
insulin-like growth factor 1 receptor
increases expression
ISO
15
99,192,761
99,507,759
RGD:6480464
CTD
G
IGF1R
insulin-like growth factor 1 receptor
increases expression
ISO
15
99,192,761
99,507,759
RGD:6480464
CTD
G
IGF1R
insulin-like growth factor 1 receptor
multiple interactions
ISO
15
99,192,761
99,507,759
RGD:6480464
CTD
G
IGFBP1
insulin-like growth factor binding protein 1
decreases expression
ISO
7
45,927,959
45,933,267
RGD:6480464
CTD
G
IGFBP1
insulin-like growth factor binding protein 1
increases expression
ISO
7
45,927,959
45,933,267
RGD:6480464
CTD
G
IGFBP3
insulin-like growth factor binding protein 3
multiple interactions
EXP
7
45,951,844
45,960,871
RGD:6480464
CTD
G
IGFBP4
insulin-like growth factor binding protein 4
increases expression
EXP
17
38,599,676
38,613,982
RGD:6480464
CTD
G
IKBKB
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
increases expression
ISO
8
42,128,820
42,190,171
RGD:6480464
CTD
G
IL10
interleukin 10
multiple interactions
ISO
1
206,940,948
206,945,839
RGD:6480464
CTD
G
IL17B
interleukin 17B
decreases expression
ISO
5
148,753,830
148,758,838
RGD:6480464
CTD
G
IL18
interleukin 18 (interferon-gamma-inducing factor)
decreases expression
ISO
11
112,013,974
112,034,840
RGD:6480464
CTD
G
IL1A
interleukin 1, alpha
multiple interactions
ISO
2
113,531,492
113,542,971
RGD:6480464
CTD
G
IL1B
interleukin 1, beta
multiple interactions
ISO
2
113,587,337
113,594,356
RGD:6480464
CTD
G
IL4
interleukin 4
increases expression
ISO
5
132,009,678
132,018,370
RGD:6480464
CTD
G
IL4R
interleukin 4 receptor
decreases expression
EXP
16
27,325,230
27,376,099
RGD:6480464
CTD
G
IL4R
interleukin 4 receptor
increases expression
ISO
16
27,325,230
27,376,099
RGD:6480464
CTD
G
IL6
interleukin 6 (interferon, beta 2)
increases expression
EXP
7
22,766,766
22,771,621
RGD:6480464
CTD
G
IL6
interleukin 6 (interferon, beta 2)
multiple interactions
ISO
7
22,766,766
22,771,621
RGD:6480464
CTD
G
IL6
interleukin 6 (interferon, beta 2)
multiple interactions
ISO
7
22,766,766
22,771,621
RGD:6480464
CTD
G
IL8
interleukin 8
multiple interactions
EXP
4
74,606,223
74,609,433
RGD:6480464
CTD
G
IL8
interleukin 8
multiple interactions
EXP
4
74,606,223
74,609,433
RGD:6480464
CTD
G
IL8
interleukin 8
decreases expression
EXP
4
74,606,223
74,609,433
RGD:6480464
CTD
G
IL8
interleukin 8
increases expression
EXP
4
74,606,223
74,609,433
RGD:6480464
CTD
G
ILF2
interleukin enhancer binding factor 2
increases expression
EXP
1
153,634,264
153,643,504
RGD:6480464
CTD
G
ILF3
interleukin enhancer binding factor 3, 90kDa
decreases expression
EXP
19
10,764,937
10,803,095
RGD:6480464
CTD
G
IMPDH2
IMP (inosine 5'-monophosphate) dehydrogenase 2
increases expression
EXP
3
49,061,758
49,066,875
RGD:6480464
CTD
G
INHBB
inhibin, beta B
increases expression
ISO
2
121,103,719
121,109,383
RGD:6480464
CTD
G
INPP4B
inositol polyphosphate-4-phosphatase, type II, 105kDa
decreases expression
EXP
4
142,949,181
143,767,604
RGD:6480464
CTD
G
INSIG1
insulin induced gene 1
increases expression
EXP
7
155,089,486
155,101,945
RGD:6480464
CTD
G
IPO13
importin 13
increases expression
EXP
1
44,412,478
44,433,694
RGD:6480464
CTD
G
IQGAP2
IQ motif containing GTPase activating protein 2
decreases expression
EXP
5
75,699,149
76,003,957
RGD:6480464
CTD
G
IRF2BP1
interferon regulatory factor 2 binding protein 1
multiple interactions
EXP
19
46,386,866
46,389,376
RGD:6480464
CTD
G
IRF7
interferon regulatory factor 7
increases expression
EXP
11
612,555
615,999
RGD:6480464
CTD
G
IRF7
interferon regulatory factor 7
increases expression
ISO
11
612,555
615,999
RGD:6480464
CTD
G
IRS2
insulin receptor substrate 2
decreases expression
EXP
13
110,406,184
110,438,914
RGD:6480464
CTD
G
ISG15
ISG15 ubiquitin-like modifier
increases expression
ISO
1
948,847
949,920
RGD:6480464
CTD
G
ITGA2
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
decreases expression
ISO
5
52,285,156
52,390,609
RGD:6480464
CTD
G
ITGA3
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
decreases expression
ISO
17
48,133,340
48,167,849
RGD:6480464
CTD
G
ITPK1
inositol-tetrakisphosphate 1-kinase
increases expression
EXP
14
93,403,259
93,582,263
RGD:6480464
CTD
G
ITPR1
inositol 1,4,5-trisphosphate receptor, type 1
increases expression
EXP
3
4,535,032
4,889,524
RGD:6480464
CTD
G
JAK3
Janus kinase 3
increases expression
ISO
19
17,935,591
17,958,841
RGD:6480464
CTD
G
JUN
jun proto-oncogene
increases activity
EXP
1
59,246,463
59,249,785
RGD:6480464
CTD
G
JUN
jun proto-oncogene
increases expression
EXP
1
59,246,463
59,249,785
RGD:6480464
CTD
G
JUN
jun proto-oncogene
multiple interactions
ISO
1
59,246,463
59,249,785
RGD:6480464
CTD
G
JUP
junction plakoglobin
decreases expression
EXP
17
39,910,859
39,942,964
RGD:6480464
CTD
G
KCNAB1
potassium voltage-gated channel, shaker-related subfamily, beta member 1
increases expression
ISO
3
155,838,337
156,256,927
RGD:6480464
CTD
G
KCNF1
potassium voltage-gated channel, subfamily F, member 1
increases expression
EXP
2
11,052,063
11,054,351
RGD:6480464
CTD
G
KCNG2
potassium voltage-gated channel, subfamily G, member 2
multiple interactions
EXP
18
77,623,668
77,659,816
RGD:6480464
CTD
G
KCNJ5
potassium inwardly-rectifying channel, subfamily J, member 5
increases expression
EXP
11
128,761,313
128,787,964
RGD:6480464
CTD
G
KLHL41
kelch-like family member 41
increases expression
ISO
2
170,366,212
170,382,772
RGD:6480464
CTD
G
KMT2A
lysine (K)-specific methyltransferase 2A
increases mutagenesis
EXP
11
118,307,205
118,397,539
RGD:6480464
CTD
G
LGALS7
lectin, galactoside-binding, soluble, 7
increases expression
ISO
19
39,261,608
39,264,157
RGD:6480464
CTD
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
decreases expression
ISO
2
48,913,913
48,982,880
RGD:6480464
CTD
G
LIG3
ligase III, DNA, ATP-dependent
decreases expression
EXP
17
33,307,517
33,332,088
RGD:6480464
CTD
G
LPAR1
lysophosphatidic acid receptor 1
increases expression
ISO
9
113,636,054
113,800,365
RGD:6480464
CTD
G
LPAR2
lysophosphatidic acid receptor 2
decreases expression
EXP
19
19,734,464
19,739,039
RGD:6480464
CTD
G
LPPR2
lipid phosphate phosphatase-related protein type 2
increases expression
EXP
19
11,466,062
11,476,374
RGD:6480464
CTD
G
LRG1
leucine-rich alpha-2-glycoprotein 1
increases expression
ISO
19
4,537,227
4,540,036
RGD:6480464
CTD
G
LRP4
low density lipoprotein receptor-related protein 4
increases expression
ISO
11
46,878,268
46,940,173
RGD:6480464
CTD
G
LSP1
lymphocyte-specific protein 1
decreases expression
ISO
11
1,874,200
1,913,493
RGD:6480464
CTD
G
LSR
lipolysis stimulated lipoprotein receptor
increases expression
ISO
19
35,739,559
35,758,867
RGD:6480464
CTD
G
LTBP4
latent transforming growth factor beta binding protein 4
decreases expression
ISO
19
41,099,072
41,135,725
RGD:6480464
CTD
G
LTF
lactotransferrin
increases expression
ISO
3
46,477,496
46,506,598
RGD:6480464
CTD
G
LY6E
lymphocyte antigen 6 complex, locus E
increases expression
ISO
8
144,099,902
144,103,827
RGD:6480464
CTD
G
MAD1L1
MAD1 mitotic arrest deficient-like 1 (yeast)
increases expression
EXP
7
1,855,428
2,272,583
RGD:6480464
CTD
G
MADD
MAP-kinase activating death domain
decreases expression
EXP
11
47,290,927
47,351,582
RGD:6480464
CTD
G
MAF
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
decreases expression
EXP
16
79,627,745
79,634,622
RGD:6480464
CTD
G
MAFB
v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)
increases expression
EXP
20
39,314,515
39,317,876
RGD:6480464
CTD
G
MAL2
mal, T-cell differentiation protein 2 (gene/pseudogene)
increases expression
ISO
8
120,220,610
120,257,913
RGD:6480464
CTD
G
MAN2B1
mannosidase, alpha, class 2B, member 1
increases expression
ISO
19
12,757,322
12,777,591
RGD:6480464
CTD
G
MAOA
monoamine oxidase A
increases expression
EXP
X
43,514,155
43,606,071
RGD:6480464
CTD
G
MAOA
monoamine oxidase A
decreases expression
ISO
X
43,514,155
43,606,071
RGD:6480464
CTD
G
MAP2K1
mitogen-activated protein kinase kinase 1
decreases phosphorylation
ISO
15
66,679,211
66,783,882
RGD:6480464
CTD
G
MAP2K2
mitogen-activated protein kinase kinase 2
decreases phosphorylation
ISO
19
4,090,319
4,124,126
RGD:6480464
CTD
G
MAP2K3
mitogen-activated protein kinase kinase 3
decreases expression
EXP
17
21,187,968
21,218,552
RGD:6480464
CTD
G
MAP4
microtubule-associated protein 4
decreases expression
EXP
3
47,892,180
48,130,769
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
decreases expression
ISO
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
ISO
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK10
mitogen-activated protein kinase 10
increases expression
ISO
4
86,936,276
87,374,283
RGD:6480464
CTD
G
MAPK11
mitogen-activated protein kinase 11
decreases phosphorylation
EXP
22
50,702,142
50,708,779
RGD:6480464
CTD
G
MAPK13
mitogen-activated protein kinase 13
decreases expression
EXP
6
36,098,261
36,112,301
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
decreases expression
ISO
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
decreases expression
ISO
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation
ISO
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MASTL
microtubule associated serine/threonine kinase-like
increases expression
EXP
10
27,443,753
27,475,848
RGD:6480464
CTD
G
MAZ
MYC-associated zinc finger protein (purine-binding transcription factor)
decreases expression
EXP
16
29,817,855
29,822,504
RGD:6480464
CTD
G
MBD2
methyl-CpG binding domain protein 2
decreases activity
EXP
18
51,677,971
51,751,158
RGD:6480464
CTD
G
MBP
myelin basic protein
increases expression
ISO
18
74,690,789
74,844,774
RGD:6480464
CTD
G
MCCC2
methylcrotonoyl-CoA carboxylase 2 (beta)
increases expression
ISO
5
70,883,115
70,954,531
RGD:6480464
CTD
G
MCM10
minichromosome maintenance complex component 10
increases expression
EXP
10
13,203,554
13,253,104
RGD:6480464
CTD
G
MCM2
minichromosome maintenance complex component 2
increases expression
EXP
3
127,317,253
127,341,279
RGD:6480464
CTD
G
MCM6
minichromosome maintenance complex component 6
increases expression
EXP
2
136,597,196
136,634,047
RGD:6480464
CTD
G
MCM7
minichromosome maintenance complex component 7
increases expression
EXP
7
99,690,404
99,699,427
RGD:6480464
CTD
G
MDK
midkine (neurite growth-promoting factor 2)
decreases expression
EXP
11
46,402,334
46,405,387
RGD:6480464
CTD
G
ME1
malic enzyme 1, NADP(+)-dependent, cytosolic
increases expression
EXP
6
83,920,108
84,140,938
RGD:6480464
CTD
G
MECP2
methyl CpG binding protein 2 (Rett syndrome)
increases expression
EXP
X
153,287,264
153,363,188
RGD:6480464
CTD
G
MED14
mediator complex subunit 14
decreases expression
EXP
X
40,508,795
40,594,804
RGD:6480464
CTD
G
MED20
mediator complex subunit 20
decreases expression
EXP
6
41,873,092
41,888,877
RGD:6480464
CTD
G
MELK
maternal embryonic leucine zipper kinase
increases expression
EXP
9
36,572,859
36,677,680
RGD:6480464
CTD
G
MEN1
multiple endocrine neoplasia I
multiple interactions
EXP
11
64,570,986
64,578,766
RGD:6480464
CTD
G
MEOX1
mesenchyme homeobox 1
decreases expression
EXP
17
41,717,757
41,739,262
RGD:6480464
CTD
G
MET
met proto-oncogene (hepatocyte growth factor receptor)
increases expression
EXP
7
116,312,459
116,438,440
RGD:6480464
CTD
G
METTL21D
methyltransferase like 21D
decreases expression
EXP
14
50,575,350
50,583,297
RGD:6480464
CTD
G
MFGE8
milk fat globule-EGF factor 8 protein
decreases expression
EXP
15
89,441,914
89,456,663
RGD:6480464
CTD
G
MFN2
mitofusin 2
increases expression
EXP
1
12,040,238
12,073,572
RGD:6480464
CTD
G
MGMT
O-6-methylguanine-DNA methyltransferase
increases expression
EXP
10
131,265,454
131,565,783
RGD:6480464
CTD
G
MGST1
microsomal glutathione S-transferase 1
decreases expression
ISO
12
16,500,076
16,530,123
RGD:6480464
CTD
G
MGST3
microsomal glutathione S-transferase 3
increases expression
ISO
1
165,600,110
165,625,373
RGD:6480464
CTD
G
MKNK2
MAP kinase interacting serine/threonine kinase 2
increases expression
ISO
19
2,037,470
2,051,243
RGD:6480464
CTD
G
MLF1
myeloid leukemia factor 1
increases expression
EXP
3
158,288,953
158,324,249
RGD:6480464
CTD
G
MLF1IP
MLF1 interacting protein
increases expression
EXP
4
185,615,219
185,655,286
RGD:6480464
CTD
G
MLKL
mixed lineage kinase domain-like
decreases expression
EXP
16
74,705,753
74,734,789
RGD:6480464
CTD
G
MLLT4
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
decreases expression
EXP
6
168,227,671
168,372,700
RGD:6480464
CTD
G
MLPH
melanophilin
increases expression
EXP
2
238,395,878
238,463,961
RGD:6480464
CTD
G
MMP14
matrix metallopeptidase 14 (membrane-inserted)
decreases expression
EXP
14
23,305,793
23,316,803
RGD:6480464
CTD
G
MMP14
matrix metallopeptidase 14 (membrane-inserted)
decreases expression
EXP
14
23,305,793
23,316,803
RGD:6480464
CTD
G
MMP15
matrix metallopeptidase 15 (membrane-inserted)
decreases expression
EXP
16
58,059,282
58,080,805
RGD:6480464
CTD
G
MMP16
matrix metallopeptidase 16 (membrane-inserted)
decreases expression
EXP
8
89,049,460
89,339,717
RGD:6480464
CTD
G
MMP2
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
decreases activity
EXP
16
55,513,081
55,540,586
RGD:6480464
CTD
G
MMP2
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
decreases expression
EXP
16
55,513,081
55,540,586
RGD:6480464
CTD
G
MMP7
matrix metallopeptidase 7 (matrilysin, uterine)
increases expression
ISO
11
102,391,239
102,401,478
RGD:6480464
CTD
G
MMP9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
decreases activity
EXP
20
44,637,547
44,645,200
RGD:6480464
CTD
G
MMP9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
decreases expression
EXP
20
44,637,547
44,645,200
RGD:6480464
CTD
G
MMP9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
decreases expression
EXP
20
44,637,547
44,645,200
RGD:6480464
CTD
G
MNT
MNT, MAX dimerization protein
increases expression
EXP
17
2,287,354
2,304,258
RGD:6480464
CTD
G
MPC1
mitochondrial pyruvate carrier 1
increases expression
ISO
6
166,778,407
166,796,501
RGD:6480464
CTD
G
MPHOSPH9
M-phase phosphoprotein 9
increases expression
EXP
12
123,640,946
123,706,441
RGD:6480464
CTD
G
MPND
MPN domain containing
increases expression
EXP
19
4,343,524
4,360,083
RGD:6480464
CTD
G
MRPL49
mitochondrial ribosomal protein L49
decreases expression
EXP
11
64,889,655
64,894,841
RGD:6480464
CTD
G
MSI2
musashi RNA-binding protein 2
decreases expression
EXP
17
55,333,931
55,757,299
RGD:6480464
CTD
G
NCMAP
noncompact myelin associated protein
increases expression
EXP
1
24,882,567
24,935,819
RGD:6480464
CTD
G
NOS2
nitric oxide synthase 2, inducible
multiple interactions
ISO
17
26,083,792
26,127,555
RGD:6480464
CTD
G
NOS2
nitric oxide synthase 2, inducible
multiple interactions
ISO
17
26,083,792
26,127,555
RGD:6480464
CTD
G
NOS2
nitric oxide synthase 2, inducible
decreases activity
ISO
17
26,083,792
26,127,555
RGD:6480464
CTD
G
NOS3
nitric oxide synthase 3 (endothelial cell)
increases activity
EXP
7
150,688,144
150,711,687
RGD:6480464
CTD
G
NOTCH2
notch 2
decreases expression
ISO
1
120,454,176
120,612,317
RGD:6480464
CTD
G
NPIP
nuclear pore complex interacting protein
decreases expression
EXP
16
15,031,300
15,045,931
RGD:6480464
CTD
G
NPPC
natriuretic peptide C
decreases expression
ISO
2
232,786,805
232,791,038
RGD:6480464
CTD
G
NQO1
NAD(P)H dehydrogenase, quinone 1
decreases expression
EXP
16
69,743,304
69,760,533
RGD:6480464
CTD
G
NQO1
NAD(P)H dehydrogenase, quinone 1
increases expression
EXP
16
69,743,304
69,760,533
RGD:6480464
CTD
G
NR1D1
nuclear receptor subfamily 1, group D, member 1
decreases expression
ISO
17
38,249,037
38,256,973
RGD:6480464
CTD
G
NR1I2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
EXP
3
119,499,331
119,537,332
RGD:6480464
CTD
G
NR2C2
nuclear receptor subfamily 2, group C, member 2
decreases expression
EXP
3
14,989,236
15,090,780
RGD:6480464
CTD
G
NR4A1
nuclear receptor subfamily 4, group A, member 1
decreases expression
EXP
12
52,416,616
52,453,291
RGD:6480464
CTD
G
NRBP1
nuclear receptor binding protein 1
decreases expression
EXP
2
27,651,473
27,665,126
RGD:6480464
CTD
G
NRGN
neurogranin (protein kinase C substrate, RC3)
decreases expression
ISO
11
124,609,829
124,617,102
RGD:6480464
CTD
G
NRIP1
nuclear receptor interacting protein 1
increases expression
EXP
21
16,333,556
16,437,126
RGD:6480464
CTD
G
NRTN
neurturin
increases expression
EXP
19
5,823,818
5,828,335
RGD:6480464
CTD
G
NTRK2
neurotrophic tyrosine kinase, receptor, type 2
increases expression
ISO
9
87,283,466
87,638,505
RGD:6480464
CTD
G
NUDT4
nudix (nucleoside diphosphate linked moiety X)-type motif 4
increases expression
ISO
12
93,771,701
93,797,024
RGD:6480464
CTD
G
NUP155
nucleoporin 155kDa
increases expression
ISO
5
37,291,941
37,371,197
RGD:6480464
CTD
G
OLFM1
olfactomedin 1
increases expression
EXP
9
137,967,089
138,013,030
RGD:6480464
CTD
G
OLFML3
olfactomedin-like 3
multiple interactions
EXP
1
114,522,030
114,524,875
RGD:6480464
CTD
G
OLFML3
olfactomedin-like 3
increases expression
EXP
1
114,522,030
114,524,875
RGD:6480464
CTD
G
OSGIN1
oxidative stress induced growth inhibitor 1
increases expression
EXP
16
83,986,827
83,999,937
RGD:6480464
CTD
G
PA2G4
proliferation-associated 2G4, 38kDa
decreases expression
EXP
12
56,498,103
56,507,694
RGD:6480464
CTD
G
PADI1
peptidyl arginine deiminase, type I
increases expression
ISO
1
17,531,621
17,572,501
RGD:6480464
CTD
G
PADI2
peptidyl arginine deiminase, type II
increases expression
ISO
1
17,393,256
17,445,948
RGD:6480464
CTD
G
PAFAH1B3
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa)
increases expression
ISO
19
42,801,185
42,806,952
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PBK
PDZ binding kinase
affects expression
EXP
8
27,667,138
27,695,349
RGD:6480464
CTD
G
PBK
PDZ binding kinase
increases expression
EXP
8
27,667,138
27,695,349
RGD:6480464
CTD
G
PCK2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
increases expression
EXP
14
24,563,483
24,573,339
RGD:6480464
CTD
G
PCNA
proliferating cell nuclear antigen
decreases expression
EXP
20
5,095,599
5,107,268
RGD:6480464
CTD
G
PCNA
proliferating cell nuclear antigen
increases expression
EXP
20
5,095,599
5,107,268
RGD:6480464
CTD
G
PCNA
proliferating cell nuclear antigen
increases expression
ISO
20
5,095,599
5,107,268
RGD:6480464
CTD
G
PCNA
proliferating cell nuclear antigen
increases expression
ISO
20
5,095,599
5,107,268
RGD:6480464
CTD
G
PCNA
proliferating cell nuclear antigen
decreases expression
ISO
20
5,095,599
5,107,268
RGD:6480464
CTD
G
PCNA
proliferating cell nuclear antigen
decreases expression
ISO
20
5,095,599
5,107,268
RGD:6480464
CTD
G
PCP4
Purkinje cell protein 4
increases expression
EXP
21
41,239,347
41,301,322
RGD:6480464
CTD
G
PDCD4
programmed cell death 4 (neoplastic transformation inhibitor)
increases expression
EXP
10
112,631,553
112,659,764
RGD:6480464
CTD
G
PDCD6IP
programmed cell death 6 interacting protein
increases expression
EXP
3
33,840,063
33,911,199
RGD:6480464
CTD
G
PDCD7
programmed cell death 7
increases expression
EXP
15
65,409,717
65,426,174
RGD:6480464
CTD
G
PDGFRA
platelet-derived growth factor receptor, alpha polypeptide
increases expression
ISO
4
55,095,264
55,164,412
RGD:6480464
CTD
G
PDGFRB
platelet-derived growth factor receptor, beta polypeptide
increases expression
ISO
5
149,493,402
149,535,422
RGD:6480464
CTD
G
PDK1
pyruvate dehydrogenase kinase, isozyme 1
decreases phosphorylation
EXP
2
173,420,779
173,463,862
RGD:6480464
CTD
G
PDLIM2
PDZ and LIM domain 2 (mystique)
multiple interactions
EXP
8
22,436,254
22,455,538
RGD:6480464
CTD
G
PDZK1
PDZ domain containing 1
increases expression
EXP
1
145,727,666
145,764,207
RGD:6480464
CTD
G
PEPD
peptidase D
increases expression
ISO
19
33,877,855
34,012,799
RGD:6480464
CTD
G
PFKFB4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
increases expression
ISO
3
48,555,117
48,594,227
RGD:6480464
CTD
G
PFKP
phosphofructokinase, platelet
increases expression
ISO
10
3,109,712
3,178,997
RGD:6480464
CTD
G
PFN1
profilin 1
increases expression
ISO
17
4,848,945
4,852,381
RGD:6480464
CTD
G
PGK1
phosphoglycerate kinase 1
increases expression
ISO
X
77,359,666
77,382,324
RGD:6480464
CTD
G
PGLYRP1
peptidoglycan recognition protein 1
increases expression
ISO
19
46,522,411
46,526,556
RGD:6480464
CTD
G
PGR
progesterone receptor
increases expression
EXP
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
increases expression
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
decreases expression
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
multiple interactions
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
decreases expression
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
increases expression
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
increases expression
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
increases expression
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PGR
progesterone receptor
multiple interactions
ISO
11
100,900,355
101,000,544
RGD:6480464
CTD
G
PHF14
PHD finger protein 14
decreases expression
EXP
7
11,013,499
11,209,250
RGD:6480464
CTD
G
PHLDA2
pleckstrin homology-like domain, family A, member 2
increases expression
EXP
11
2,949,503
2,950,650
RGD:6480464
CTD
G
PIAS3
protein inhibitor of activated STAT, 3
decreases expression
ISO
1
145,575,988
145,586,546
RGD:6480464
CTD
G
PIGR
polymeric immunoglobulin receptor
increases expression
ISO
1
207,101,867
207,119,811
RGD:6480464
CTD
G
PIK3R2
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
decreases expression
EXP
19
18,264,016
18,281,343
RGD:6480464
CTD
G
PIK3R3
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
increases expression
EXP
1
46,505,812
46,598,708
RGD:6480464
CTD
G
PILRB
paired immunoglobin-like type 2 receptor beta
decreases expression
EXP
7
99,933,688
99,965,454
RGD:6480464
CTD
G
PIM1
pim-1 oncogene
increases expression
EXP
6
37,137,922
37,143,204
RGD:6480464
CTD
G
PIM3
pim-3 oncogene
increases expression
ISO
22
50,354,143
50,357,720
RGD:6480464
CTD
G
PKM
pyruvate kinase, muscle
increases expression
ISO
15
72,491,370
72,523,727
RGD:6480464
CTD
G
PKP2
plakophilin 2
increases expression
ISO
12
32,943,680
33,049,780
RGD:6480464
CTD
G
PLA2G1B
phospholipase A2, group IB (pancreas)
decreases expression
ISO
12
120,759,914
120,765,592
RGD:6480464
CTD
G
PLAU
plasminogen activator, urokinase
increases expression
EXP
10
75,670,862
75,677,259
RGD:6480464
CTD
G
PLAU
plasminogen activator, urokinase
increases expression
ISO
10
75,670,862
75,677,259
RGD:6480464
CTD
G
PLCB1
phospholipase C, beta 1 (phosphoinositide-specific)
increases expression
EXP
20
8,113,296
8,865,547
RGD:6480464
CTD
G
PLD1
phospholipase D1, phosphatidylcholine-specific
multiple interactions
ISO
3
171,318,195
171,528,284
RGD:6480464
CTD
G
PLD3
phospholipase D family, member 3
increases expression
ISO
19
40,854,332
40,884,390
RGD:6480464
CTD
G
PLEC
plectin
decreases expression
EXP
8
144,989,321
145,050,913
RGD:6480464
CTD
G
PLK3
polo-like kinase 3
multiple interactions
ISO
1
45,266,036
45,271,667
RGD:6480464
CTD
G
PLK4
polo-like kinase 4
increases expression
EXP
4
128,802,016
128,820,379
RGD:6480464
CTD
G
PLOD1
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
increases expression
EXP
1
11,994,724
12,035,599
RGD:6480464
CTD
G
PLOD2
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2
increases expression
ISO
3
145,787,227
145,879,282
RGD:6480464
CTD
G
PLP1
proteolipid protein 1
decreases expression
EXP
X
103,031,439
103,047,548
RGD:6480464
CTD
G
PLXNB1
plexin B1
decreases expression
EXP
3
48,445,261
48,471,460
RGD:6480464
CTD
G
PMEPA1
prostate transmembrane protein, androgen induced 1
decreases expression
EXP
20
56,223,448
56,286,592
RGD:6480464
CTD
G
PNN
pinin, desmosome associated protein
multiple interactions
EXP
14
39,644,387
39,652,422
RGD:6480464
CTD
G
PNRC1
proline-rich nuclear receptor coactivator 1
multiple interactions
EXP
6
89,790,429
89,794,879
RGD:6480464
CTD
G
POLD4
polymerase (DNA-directed), delta 4, accessory subunit
decreases expression
EXP
11
67,118,236
67,121,067
RGD:6480464
CTD
G
POLR2C
polymerase (RNA) II (DNA directed) polypeptide C, 33kDa
increases expression
EXP
16
57,496,551
57,505,921
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTK2
protein tyrosine kinase 2
increases phosphorylation
EXP
8
141,668,481
142,011,412
RGD:6480464
CTD
G
PTMS
parathymosin
decreases expression
EXP
12
6,875,541
6,880,118
RGD:6480464
CTD
G
PTPN1
protein tyrosine phosphatase, non-receptor type 1
increases expression
ISO
20
49,126,891
49,201,088
RGD:6480464
CTD
G
PTPRA
protein tyrosine phosphatase, receptor type, A
decreases expression
ISO
20
2,844,841
3,019,315
RGD:6480464
CTD
G
PTPRA
protein tyrosine phosphatase, receptor type, A
increases expression
ISO
20
2,844,841
3,019,315
RGD:6480464
CTD
G
PWP2
PWP2 periodic tryptophan protein homolog (yeast)
decreases expression
EXP
21
45,527,208
45,551,063
RGD:6480464
CTD
G
PZP
pregnancy-zone protein
increases expression
EXP
12
9,301,436
9,360,966
RGD:6480464
CTD
G
QRICH1
glutamine-rich 1
multiple interactions
EXP
3
49,067,142
49,131,504
RGD:6480464
CTD
G
QSOX1
quiescin Q6 sulfhydryl oxidase 1
increases expression
ISO
1
180,123,968
180,167,169
RGD:6480464
CTD
G
QSOX1
quiescin Q6 sulfhydryl oxidase 1
increases expression
ISO
1
180,123,968
180,167,169
RGD:6480464
CTD
G
RAB11B
RAB11B, member RAS oncogene family
decreases expression
EXP
19
8,455,205
8,469,318
RGD:6480464
CTD
G
RAB14
RAB14, member RAS oncogene family
increases expression
ISO
9
123,940,415
123,964,365
RGD:6480464
CTD
G
RAB25
RAB25, member RAS oncogene family
increases expression
ISO
1
156,030,966
156,040,295
RGD:6480464
CTD
G
RACGAP1
Rac GTPase activating protein 1
increases expression
EXP
12
50,382,945
50,419,307
RGD:6480464
CTD
G
RAD51
RAD51 homolog (S. cerevisiae)
increases expression
EXP
15
40,987,327
41,024,356
RGD:6480464
CTD
G
RAD51AP1
RAD51 associated protein 1
increases expression
EXP
12
4,647,950
4,669,213
RGD:6480464
CTD
G
RAD51C
RAD51 homolog C (S. cerevisiae)
increases expression
EXP
17
56,769,963
56,811,692
RGD:6480464
CTD
G
RAF1
v-raf-1 murine leukemia viral oncogene homolog 1
decreases phosphorylation
ISO
3
12,625,100
12,705,700
RGD:6480464
CTD
G
RALGAPA1
Ral GTPase activating protein, alpha subunit 1 (catalytic)
increases expression
ISO
14
36,007,558
36,278,432
RGD:6480464
CTD
G
RANGAP1
Ran GTPase activating protein 1
decreases expression
EXP
22
41,641,615
41,682,216
RGD:6480464
CTD
G
RARRES3
retinoic acid receptor responder (tazarotene induced) 3
increases expression
EXP
11
63,304,273
63,313,930
RGD:6480464
CTD
G
RASA4
RAS p21 protein activator 4
increases expression
ISO
7
102,220,093
102,257,205
RGD:6480464
CTD
G
RASSF2
Ras association (RalGDS/AF-6) domain family member 2
increases expression
ISO
20
4,760,669
4,804,291
RGD:6480464
CTD
G
RB1
retinoblastoma 1
multiple interactions
EXP
13
48,877,883
49,056,026
RGD:6480464
CTD
G
RBBP8
retinoblastoma binding protein 8
increases expression
EXP
18
20,513,295
20,606,449
RGD:6480464
CTD
G
RBP1
retinol binding protein 1, cellular
decreases expression
EXP
3
139,236,276
139,258,671
RGD:6480464
CTD
G
RBP4
retinol binding protein 4, plasma
decreases expression
ISO
10
95,351,593
95,360,993
RGD:6480464
CTD
G
RCVRN
recoverin
decreases expression
ISO
17
9,801,027
9,808,684
RGD:6480464
CTD
G
REEP5
receptor accessory protein 5
increases expression
ISO
5
112,212,081
112,258,031
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
affects localization
EXP
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
decreases expression
EXP
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
decreases expression
ISO
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RET
ret proto-oncogene
increases expression
ISO
10
43,572,517
43,625,799
RGD:6480464
CTD
G
RETN
resistin
multiple interactions
ISO
19
7,733,972
7,735,340
RGD:6480464
CTD
G
RFC3
replication factor C (activator 1) 3, 38kDa
increases expression
ISO
13
34,392,206
34,540,695
RGD:6480464
CTD
G
RGS10
regulator of G-protein signaling 10
increases expression
EXP
10
121,259,339
121,302,222
RGD:6480464
CTD
G
RGS16
regulator of G-protein signaling 16
decreases expression
EXP
1
182,567,758
182,573,548
RGD:6480464
CTD
G
RMI2
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae)
decreases expression
EXP
16
11,439,311
11,445,617
RGD:6480464
CTD
G
RNASEH1
ribonuclease H1
increases expression
EXP
2
3,592,678
3,605,940
RGD:6480464
CTD
G
RNFT2
ring finger protein, transmembrane 2
increases expression
EXP
12
117,176,096
117,291,436
RGD:6480464
CTD
G
ROPN1L
rhophilin associated tail protein 1-like
increases expression
EXP
5
10,441,974
10,465,138
RGD:6480464
CTD
G
ROS1
c-ros oncogene 1 , receptor tyrosine kinase
decreases expression
ISO
6
117,609,530
117,747,018
RGD:6480464
CTD
G
RPH3A
rabphilin 3A homolog (mouse)
increases expression
ISO
12
113,229,549
113,336,686
RGD:6480464
CTD
G
RPL28
ribosomal protein L28
increases expression
EXP
19
55,897,300
55,903,453
RGD:6480464
CTD
G
RPL39
ribosomal protein L39
increases expression
ISO
X X
118,920,469 118,923,864
118,925,606 118,923,974
RGD:6480464
CTD
G
RPN2
ribophorin II
increases expression
ISO
20
35,807,456
35,870,026
RGD:6480464
CTD
G
RPS11
ribosomal protein S11
decreases expression
EXP
19
49,999,622
50,002,969
RGD:6480464
CTD
G
RPS19
ribosomal protein S19
decreases expression
EXP
19
42,363,988
42,375,484
RGD:6480464
CTD
G
RPS6KA3
ribosomal protein S6 kinase, 90kDa, polypeptide 3
increases expression
EXP
X
20,168,029
20,284,750
RGD:6480464
CTD
G
RRAD
Ras-related associated with diabetes
decreases expression
EXP
16
66,955,582
66,959,439
RGD:6480464
CTD
G
RRM2
ribonucleotide reductase M2
increases expression
EXP
2
10,262,695
10,271,546
RGD:6480464
CTD
G
RRM2B
ribonucleotide reductase M2 B (TP53 inducible)
increases expression
EXP
8
103,216,729
103,251,346
RGD:6480464
CTD
G
RUNX2
runt-related transcription factor 2
affects expression
ISO
6
45,296,054
45,518,819
RGD:6480464
CTD
G
RYK
receptor-like tyrosine kinase
increases expression
ISO
3
133,875,978
133,969,586
RGD:6480464
CTD
G
S100G
S100 calcium binding protein G
decreases expression
ISO
X
16,668,281
16,672,791
RGD:6480464
CTD
G
S100G
S100 calcium binding protein G
affects expression
ISO
X
16,668,281
16,672,791
RGD:6480464
CTD
G
S100G
S100 calcium binding protein G
increases expression
ISO
X
16,668,281
16,672,791
RGD:6480464
CTD
G
S1PR3
sphingosine-1-phosphate receptor 3
increases expression
EXP
9
91,606,324
91,620,070
RGD:6480464
CTD
G
SAC3D1
SAC3 domain containing 1
increases expression
EXP
11
64,808,376
64,812,300
RGD:6480464
CTD
G
SAT1
spermidine/spermine N1-acetyltransferase 1
increases expression
ISO
X
23,801,275
23,804,327
RGD:6480464
CTD
G
SC5D
sterol-C5-desaturase
increases expression
ISO
11
121,163,388
121,184,119
RGD:6480464
CTD
G
SCARB2
scavenger receptor class B, member 2
increases expression
ISO
4
77,079,890
77,135,052
RGD:6480464
CTD
G
SCD
stearoyl-CoA desaturase (delta-9-desaturase)
decreases expression
EXP
10
102,106,772
102,124,588
RGD:6480464
CTD
G
SCD
stearoyl-CoA desaturase (delta-9-desaturase)
increases expression
EXP
10
102,106,772
102,124,588
RGD:6480464
CTD
G
SCD
stearoyl-CoA desaturase (delta-9-desaturase)
decreases expression
ISO
10
102,106,772
102,124,588
RGD:6480464
CTD
G
SCGB1C1
secretoglobin, family 1C, member 1
increases expression
ISO
11
193,080
194,573
RGD:6480464
CTD
G
SCN7A
sodium channel, voltage-gated, type VII, alpha subunit
increases expression
ISO
2
167,260,083
167,343,481
RGD:6480464
CTD
G
SCN8A
sodium channel, voltage gated, type VIII, alpha subunit
decreases expression
EXP
12
51,985,020
52,206,648
RGD:6480464
CTD
G
SCPEP1
serine carboxypeptidase 1
decreases expression
ISO
17
55,055,468
55,084,129
RGD:6480464
CTD
G
SEC24D
SEC24 family, member D (S. cerevisiae)
increases expression
EXP
4
119,643,978
119,757,326
RGD:6480464
CTD
G
SEC61A1
Sec61 alpha 1 subunit (S. cerevisiae)
decreases expression
EXP
3
127,771,212
127,790,526
RGD:6480464
CTD
G
SELENBP1
selenium binding protein 1
decreases expression
EXP
1
151,336,778
151,345,210
RGD:6480464
CTD
G
SERP1
stress-associated endoplasmic reticulum protein 1
increases expression
ISO
3
150,259,780
150,264,428
RGD:6480464
CTD
G
SERPINA1
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
decreases expression
EXP
14
94,843,084
94,857,029
RGD:6480464
CTD
G
SERPINA1
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
decreases expression
ISO
14
94,843,084
94,857,029
RGD:6480464
CTD
G
SERPINB9
serpin peptidase inhibitor, clade B (ovalbumin), member 9
increases expression
ISO
6
2,887,499
2,903,546
RGD:6480464
CTD
G
SESN1
sestrin 1
increases expression
EXP
6
109,307,640
109,415,708
RGD:6480464
CTD
G
SF3B5
splicing factor 3b, subunit 5, 10kDa
increases expression
EXP
6
144,416,018
144,416,754
RGD:6480464
CTD
G
SFRP2
secreted frizzled-related protein 2
increases expression
ISO
4
154,701,742
154,710,228
RGD:6480464
CTD
G
SFRP4
secreted frizzled-related protein 4
decreases expression
EXP
7
37,945,534
37,956,525
RGD:6480464
CTD
G
SFXN2
sideroflexin 2
increases expression
EXP
10
104,474,298
104,498,946
RGD:6480464
CTD
G
SGK1
serum/glucocorticoid regulated kinase 1
multiple interactions
EXP
6
134,490,384
134,639,196
RGD:6480464
CTD
G
SGK1
serum/glucocorticoid regulated kinase 1
decreases expression
EXP
6
134,490,384
134,639,196
RGD:6480464
CTD
G
SGK1
serum/glucocorticoid regulated kinase 1
increases expression
ISO
6
134,490,384
134,639,196
RGD:6480464
CTD
G
SGPP1
sphingosine-1-phosphate phosphatase 1
multiple interactions
EXP
14
64,150,934
64,194,756
RGD:6480464
CTD
G
SHBG
sex hormone-binding globulin
increases expression
EXP
17
7,517,382
7,536,700
RGD:6480464
CTD
G
SHISA5
shisa homolog 5 (Xenopus laevis)
increases expression
ISO
3
48,509,197
48,541,661
RGD:6480464
CTD
G
SHOX2
short stature homeobox 2
decreases expression
EXP
3
157,813,800
157,823,952
RGD:6480464
CTD
G
SIRT1
sirtuin 1
affects localization
EXP
10
69,644,427
69,678,147
RGD:6480464
CTD
G
SIRT1
sirtuin 1
multiple interactions
EXP
10
69,644,427
69,678,147
RGD:6480464
CTD
G
SLC5A5
solute carrier family 5 (sodium iodide symporter), member 5
increases expression
EXP
19
17,982,782
18,005,983
RGD:6480464
CTD
G
SMC5
structural maintenance of chromosomes 5
decreases expression
EXP
9
72,873,878
72,969,789
RGD:6480464
CTD
G
SMG1
smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans)
decreases expression
EXP
16
18,816,175
18,937,726
RGD:6480464
CTD
G
SMPDL3A
sphingomyelin phosphodiesterase, acid-like 3A
decreases expression
ISO
6
123,109,971
123,130,865
RGD:6480464
CTD
G
SNCG
synuclein, gamma (breast cancer-specific protein 1)
increases expression
ISO
10
88,718,288
88,723,017
RGD:6480464
CTD
G
SNRPA
small nuclear ribonucleoprotein polypeptide A
decreases expression
EXP
19
41,256,759
41,271,297
RGD:6480464
CTD
G
SNRPB2
small nuclear ribonucleoprotein polypeptide B
increases expression
ISO
20
16,710,609
16,722,417
RGD:6480464
CTD
G
SNX1
sorting nexin 1
increases expression
ISO
15
64,388,083
64,436,433
RGD:6480464
CTD
G
SOCS3
suppressor of cytokine signaling 3
increases expression
EXP
17
76,352,859
76,356,158
RGD:6480464
CTD
G
SOCS3
suppressor of cytokine signaling 3
multiple interactions
EXP
17
76,352,859
76,356,158
RGD:6480464
CTD
G
SOD1
superoxide dismutase 1, soluble
increases expression
EXP
21
33,031,935
33,041,244
RGD:6480464
CTD
G
SOD2
superoxide dismutase 2, mitochondrial
multiple interactions
EXP
6
160,100,148
160,114,353
RGD:6480464
CTD
G
SOD2
superoxide dismutase 2, mitochondrial
multiple interactions
ISO
6
160,100,148
160,114,353
RGD:6480464
CTD
G
SORBS1
sorbin and SH3 domain containing 1
increases expression
EXP
10
97,071,530
97,321,171
RGD:6480464
CTD
G
SORD
sorbitol dehydrogenase
decreases expression
EXP
15
45,315,302
45,367,287
RGD:6480464
CTD
G
SOX2
SRY (sex determining region Y)-box 2
decreases expression
EXP
3
181,429,712
181,432,224
RGD:6480464
CTD
G
SOX4
SRY (sex determining region Y)-box 4
decreases expression
EXP
6
21,593,972
21,598,850
RGD:6480464
CTD
G
SP1
Sp1 transcription factor
multiple interactions
EXP
12
53,773,979
53,810,230
RGD:6480464
CTD
G
SP1
Sp1 transcription factor
increases activity
EXP
12
53,773,979
53,810,230
RGD:6480464
CTD
G
SPAG5
sperm associated antigen 5
affects expression
EXP
17
26,904,583
26,926,056
RGD:6480464
CTD
G
SPATA2L
spermatogenesis associated 2-like
decreases expression
EXP
16
89,762,765
89,768,121
RGD:6480464
CTD
G
SPATA31D4
SPATA31 subfamily D, member 4
increases expression
ISO
9
84,543,343
84,549,913
RGD:6480464
CTD
G
SPDEF
SAM pointed domain containing ets transcription factor
decreases expression
EXP
6
34,505,579
34,524,110
RGD:6480464
CTD
G
SPIN1
spindlin 1
decreases expression
EXP
9
91,003,297
91,093,623
RGD:6480464
CTD
G
SPP1
secreted phosphoprotein 1
increases expression
ISO
4
88,896,802
88,904,563
RGD:6480464
CTD
G
SPRR1A
small proline-rich protein 1A
increases expression
ISO
1
152,956,564
152,958,290
RGD:6480464
CTD
G
SPRR1A
small proline-rich protein 1A
increases expression
ISO
1
152,956,564
152,958,290
RGD:6480464
CTD
G
SPRR2A
small proline-rich protein 2A
increases expression
ISO
1
153,028,596
153,029,988
RGD:6480464
CTD
G
SPRR2B
small proline-rich protein 2B
increases expression
ISO
1
153,042,717
153,044,084
RGD:6480464
CTD
G
SPRR2C
small proline-rich protein 2C (pseudogene)
increases expression
ISO
1
153,112,594
153,113,969
RGD:6480464
CTD
G
SPRR2E
small proline-rich protein 2E
increases expression
ISO
1
153,065,611
153,067,001
RGD:6480464
CTD
G
SPRR2F
small proline-rich protein 2F
increases expression
ISO
1
153,084,612
153,085,989
RGD:6480464
CTD
G
SPRR2G
small proline-rich protein 2G
increases expression
ISO
1
153,122,058
153,123,427
RGD:6480464
CTD
G
SPSB1
splA/ryanodine receptor domain and SOCS box containing 1
increases expression
ISO
1
9,352,941
9,429,591
RGD:6480464
CTD
G
SPSB3
splA/ryanodine receptor domain and SOCS box containing 3
decreases expression
EXP
16
1,826,713
1,832,581
RGD:6480464
CTD
G
SPTLC2
serine palmitoyltransferase, long chain base subunit 2
increases expression
ISO
14
77,972,340
78,083,110
RGD:6480464
CTD
G
SQLE
squalene epoxidase
decreases expression
EXP
8
126,010,720
126,034,525
RGD:6480464
CTD
G
SQSTM1
sequestosome 1
decreases expression
EXP
5
179,233,388
179,265,078
RGD:6480464
CTD
G
SRC
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
decreases activity
ISO
20
35,973,088
36,033,821
RGD:6480464
CTD
G
SRCRB4D
scavenger receptor cysteine rich domain containing, group B (4 domains)
decreases expression
EXP
7
76,018,646
76,039,012
RGD:6480464
CTD
G
SRXN1
sulfiredoxin 1
increases expression
EXP
20
627,259
633,890
RGD:6480464
CTD
G
STAR
steroidogenic acute regulatory protein
increases expression
EXP
8
38,000,218
38,008,600
RGD:6480464
CTD
G
STAR
steroidogenic acute regulatory protein
decreases expression
ISO
8
38,000,218
38,008,600
RGD:6480464
CTD
G
STAR
steroidogenic acute regulatory protein
decreases expression
ISO
8
38,000,218
38,008,600
RGD:6480464
CTD
G
STARD3
StAR-related lipid transfer (START) domain containing 3
increases expression
ISO
17
37,793,333
37,820,454
RGD:6480464
CTD
G
STAT1
signal transducer and activator of transcription 1, 91kDa
multiple interactions
ISO
2
191,833,762
191,878,976
RGD:6480464
CTD
G
STAT3
signal transducer and activator of transcription 3 (acute-phase response factor)
increases expression
ISO
17
40,465,343
40,540,513
RGD:6480464
CTD
G
STC1
stanniocalcin 1
multiple interactions
EXP
8
23,699,434
23,712,320
RGD:6480464
CTD
G
STC1
stanniocalcin 1
increases expression
ISO
8
23,699,434
23,712,320
RGD:6480464
CTD
G
STC2
stanniocalcin 2
increases expression
EXP
5
172,741,726
172,756,506
RGD:6480464
CTD
G
STEAP1
six transmembrane epithelial antigen of the prostate 1
decreases expression
EXP
7
89,783,689
89,794,141
RGD:6480464
CTD
G
STK17B
serine/threonine kinase 17b
increases expression
ISO
2
196,998,307
197,036,336
RGD:6480464
CTD
G
STK39
serine threonine kinase 39
decreases expression
EXP
2
168,810,530
169,104,105
RGD:6480464
CTD
G
STMN1
stathmin 1
increases expression
EXP
1
26,210,677
26,233,368
RGD:6480464
CTD
G
SULF2
sulfatase 2
increases expression
EXP
20
46,286,150
46,415,360
RGD:6480464
CTD
G
SULT1A1
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
multiple interactions
EXP
16
28,616,908
28,634,907
RGD:6480464
CTD
G
SULT1A3
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
multiple interactions
EXP
16
30,210,549
30,215,650
RGD:6480464
CTD
G
SULT1E1
sulfotransferase family 1E, estrogen-preferring, member 1
decreases activity
EXP
4
70,706,930
70,725,870
RGD:6480464
CTD
G
SURF4
surfeit 4
decreases expression
EXP
9
136,228,340
136,242,970
RGD:6480464
CTD
G
TACC3
transforming, acidic coiled-coil containing protein 3
increases expression
EXP
4
1,723,217
1,746,905
RGD:6480464
CTD
G
TACR3
tachykinin receptor 3
multiple interactions
EXP
4
104,510,625
104,640,973
RGD:6480464
CTD
G
TACSTD2
tumor-associated calcium signal transducer 2
increases expression
ISO
1
59,041,095
59,043,166
RGD:6480464
CTD
G
TBR1
T-box, brain, 1
decreases expression
ISO
2
162,272,620
162,281,573
RGD:6480464
CTD
G
TCF21
transcription factor 21
decreases expression
ISO
6
134,210,259
134,216,675
RGD:6480464
CTD
G
TCF25
transcription factor 25 (basic helix-loop-helix)
decreases expression
EXP
16
89,939,994
89,977,792
RGD:6480464
CTD
G
TCF4
transcription factor 4
decreases expression
EXP
18
52,889,562
53,303,188
RGD:6480464
CTD
G
TEAD3
TEA domain family member 3
decreases expression
EXP
6
35,441,374
35,464,861
RGD:6480464
CTD
G
TELO2
TEL2, telomere maintenance 2, homolog (S. cerevisiae)
decreases expression
EXP
16
1,543,352
1,560,460
RGD:6480464
CTD
G
TFF1
trefoil factor 1
increases expression
EXP
21
43,782,391
43,786,644
RGD:6480464
CTD
G
TFF3
trefoil factor 3 (intestinal)
increases expression
EXP
21
43,731,777
43,735,706
RGD:6480464
CTD
G
TFPI
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
decreases expression
EXP
2
188,328,957
188,419,219
RGD:6480464
CTD
G
TFPI
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
increases expression
ISO
2
188,328,957
188,419,219
RGD:6480464
CTD
G
TFRC
transferrin receptor (p90, CD71)
increases expression
ISO
3
195,776,155
195,809,032
RGD:6480464
CTD
G
TGFA
transforming growth factor, alpha
multiple interactions
EXP
2
70,674,412
70,781,147
RGD:6480464
CTD
G
TGFA
transforming growth factor, alpha
increases expression
EXP
2
70,674,412
70,781,147
RGD:6480464
CTD
G
TGFB1
transforming growth factor, beta 1
multiple interactions
ISO
19
41,836,812
41,859,831
RGD:6480464
CTD
G
TGFB2
transforming growth factor, beta 2
decreases expression
EXP
1
218,518,676
218,617,961
RGD:6480464
CTD
G
TGFB3
transforming growth factor, beta 3
increases expression
EXP
14
76,424,442
76,448,092
RGD:6480464
CTD
G
TGFBI
transforming growth factor, beta-induced, 68kDa
decreases expression
ISO
5
135,364,584
135,399,507
RGD:6480464
CTD
G
TH
tyrosine hydroxylase
affects expression
ISO
11
2,185,159
2,193,035
RGD:6480464
CTD
G
THBS1
thrombospondin 1
increases expression
EXP
15
39,873,280
39,889,668
RGD:6480464
CTD
G
THEM6
thioesterase superfamily member 6
increases expression
EXP
8
143,808,621
143,818,350
RGD:6480464
CTD
G
THRSP
thyroid hormone responsive
increases expression
ISO
11
77,774,907
77,779,403
RGD:6480464
CTD
G
TIA1
TIA1 cytotoxic granule-associated RNA binding protein
increases expression
EXP
2
70,436,576
70,475,779
RGD:6480464
CTD
G
TIMM8A
translocase of inner mitochondrial membrane 8 homolog A (yeast)
increases expression
ISO
X
100,600,644
100,603,957
RGD:6480464
CTD
G
TIMM8A
translocase of inner mitochondrial membrane 8 homolog A (yeast)
increases expression
ISO
X
100,600,644
100,603,957
RGD:6480464
CTD
G
TIMP1
TIMP metallopeptidase inhibitor 1
decreases expression
EXP
X
47,441,690
47,446,190
RGD:6480464
CTD
G
TIMP2
TIMP metallopeptidase inhibitor 2
decreases expression
EXP
17
76,849,059
76,921,472
RGD:6480464
CTD
G
TIMP3
TIMP metallopeptidase inhibitor 3
decreases expression
EXP
22
33,196,802
33,259,028
RGD:6480464
CTD
G
TINF2
TERF1 (TRF1)-interacting nuclear factor 2
decreases expression
EXP
14
24,708,849
24,711,880
RGD:6480464
CTD
G
TJP1
tight junction protein 1
decreases expression
ISO
15
29,992,356
30,114,706
RGD:6480464
CTD
G
TK1
thymidine kinase 1, soluble
increases expression
EXP
17
76,170,160
76,183,285
RGD:6480464
CTD
G
TKT
transketolase
decreases expression
EXP
3
53,258,723
53,290,130
RGD:6480464
CTD
G
TMCC2
transmembrane and coiled-coil domain family 2
decreases expression
EXP
1
205,197,038
205,242,471
RGD:6480464
CTD
G
TMED9
transmembrane emp24 protein transport domain containing 9
decreases expression
EXP
5
177,019,213
177,023,108
RGD:6480464
CTD
G
TMEM121
transmembrane protein 121
decreases expression
EXP
14
105,992,953
105,996,539
RGD:6480464
CTD
G
TMEM38B
transmembrane protein 38B
increases expression
EXP
9
108,456,825
108,537,444
RGD:6480464
CTD
G
TMEM54
transmembrane protein 54
decreases expression
EXP
1
33,360,196
33,366,953
RGD:6480464
CTD
G
TMEM97
transmembrane protein 97
increases expression
EXP
17
26,646,121
26,655,711
RGD:6480464
CTD
G
TMPO
thymopoietin
increases expression
EXP
12
98,909,351
98,944,157
RGD:6480464
CTD
G
TMPRSS2
transmembrane protease, serine 2
decreases expression
EXP
21
42,836,478
42,880,085
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
EXP
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
EXP
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
EXP
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
EXP
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TTK
TTK protein kinase
affects expression
EXP
6
80,714,322
80,752,244
RGD:6480464
CTD
G
TUBB
tubulin, beta class I
decreases expression
EXP
6
30,688,157
30,693,199
RGD:6480464
CTD
G
TUBB6
tubulin, beta 6 class V
increases expression
EXP
18
12,308,257
12,326,568
RGD:6480464
CTD
G
TULP3
tubby like protein 3
decreases expression
EXP
12
3,000,033
3,050,306
RGD:6480464
CTD
G
TWIST2
twist basic helix-loop-helix transcription factor 2
increases expression
ISO
2
239,756,673
239,795,893
RGD:6480464
CTD
G
TXLNA
taxilin alpha
decreases expression
EXP
1
32,645,345
32,663,886
RGD:6480464
CTD
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
12
104,609,557
104,744,085
RGD:6480464
CTD
G
TYMS
thymidylate synthetase
increases expression
EXP
18
657,604
673,499
RGD:6480464
CTD
G
UAP1
UDP-N-acteylglucosamine pyrophosphorylase 1
decreases expression
EXP
1
162,531,296
162,569,633
RGD:6480464
CTD
G
UBAP2L
ubiquitin associated protein 2-like
decreases expression
EXP
1
154,192,655
154,243,329
RGD:6480464
CTD
G
UBE2C
ubiquitin-conjugating enzyme E2C
affects expression
EXP
20
44,441,255
44,445,596
RGD:6480464
CTD
G
UBE2C
ubiquitin-conjugating enzyme E2C
increases expression
EXP
20
44,441,255
44,445,596
RGD:6480464
CTD
G
UBE2D3
ubiquitin-conjugating enzyme E2D 3
increases expression
ISO
4
103,717,133
103,790,032
RGD:6480464
CTD
G
UBE2M
ubiquitin-conjugating enzyme E2M
increases expression
ISO
19
59,067,079
59,070,343
RGD:6480464
CTD
G
UBE2T
ubiquitin-conjugating enzyme E2T (putative)
increases expression
EXP
1
202,300,785
202,311,094
RGD:6480464
CTD
G
UBL3
ubiquitin-like 3
increases expression
ISO
13
30,338,545
30,424,820
RGD:6480464
CTD
G
UCHL1
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
multiple interactions
EXP
4
41,258,898
41,270,446
RGD:6480464
CTD
G
UCHL1
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
decreases expression
ISO
4
41,258,898
41,270,446
RGD:6480464
CTD
G
UGDH
UDP-glucose 6-dehydrogenase
increases expression
EXP
4
39,500,375
39,529,218
RGD:6480464
CTD
G
UGT1A1
UDP glucuronosyltransferase 1 family, polypeptide A1
decreases activity
EXP
2
234,668,919
234,681,945
RGD:6480464
CTD
G
UGT1A1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases glucuronidation
EXP
2
234,668,919
234,681,945
RGD:6480464
CTD
G
UGT1A10
UDP glucuronosyltransferase 1 family, polypeptide A10
increases glucuronidation
EXP
2
234,545,123
234,681,951
RGD:6480464
CTD
G
UGT1A3
UDP glucuronosyltransferase 1 family, polypeptide A3
increases glucuronidation
EXP
2
234,637,773
234,681,945
RGD:6480464
CTD
G
UGT1A3
UDP glucuronosyltransferase 1 family, polypeptide A3
decreases expression
EXP
2
234,637,773
234,681,945
RGD:6480464
CTD
G
UGT1A7
UDP glucuronosyltransferase 1 family, polypeptide A7
increases glucuronidation
EXP
2
234,590,584
234,681,945
RGD:6480464
CTD
G
UGT1A8
UDP glucuronosyltransferase 1 family, polypeptide A8
increases glucuronidation
EXP
2
234,526,291
234,681,945
RGD:6480464
CTD
G
UGT1A9
UDP glucuronosyltransferase 1 family, polypeptide A9
increases glucuronidation
EXP
2
234,580,544
234,681,951
RGD:6480464
CTD
G
UGT2B15
UDP glucuronosyltransferase 2 family, polypeptide B15
increases expression
EXP
4
69,512,315
69,536,494
RGD:6480464
CTD
G
UGT2B17
UDP glucuronosyltransferase 2 family, polypeptide B17
increases expression
EXP
4
69,402,902
69,434,245
RGD:6480464
CTD
G
UHRF1
ubiquitin-like with PHD and ring finger domains 1
increases expression
EXP
19
4,909,510
4,962,165
RGD:6480464
CTD
G
UNG
uracil-DNA glycosylase
increases expression
EXP
12
109,535,399
109,548,798
RGD:6480464
CTD
G
UOX
urate oxidase, pseudogene
increases expression
ISO
1
84,830,641
84,863,576
RGD:6480464
CTD
G
USP20
ubiquitin specific peptidase 20
decreases expression
EXP
9
132,597,696
132,644,107
RGD:6480464
CTD
G
VCAM1
vascular cell adhesion molecule 1
multiple interactions
EXP
1
101,185,196
101,204,601
RGD:6480464
CTD
G
VCAM1
vascular cell adhesion molecule 1
multiple interactions
EXP
1
101,185,196
101,204,601
RGD:6480464
CTD
G
VDAC1
voltage-dependent anion channel 1
increases expression
ISO
5
133,307,566
133,340,824
RGD:6480464
CTD
G
VDR
vitamin D (1,25- dihydroxyvitamin D3) receptor
multiple interactions
EXP
12
48,235,320
48,298,814
RGD:6480464
CTD
G
VDR
vitamin D (1,25- dihydroxyvitamin D3) receptor
multiple interactions
EXP
12
48,235,320
48,298,814
RGD:6480464
CTD
G
VDR
vitamin D (1,25- dihydroxyvitamin D3) receptor
increases expression
EXP
12
48,235,320
48,298,814
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
multiple interactions
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
multiple interactions
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
increases secretion
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VLDLR
very low density lipoprotein receptor
increases expression
ISO
9
2,621,793
2,654,485
RGD:6480464
CTD
G
WARS
tryptophanyl-tRNA synthetase
increases expression
EXP
14
100,800,125
100,842,680
RGD:6480464
CTD
G
WDR4
WD repeat domain 4
decreases expression
EXP
21
44,263,190
44,299,699
RGD:6480464
CTD
G
WFDC2
WAP four-disulfide core domain 2
increases expression
ISO
20
44,098,394
44,110,172
RGD:6480464
CTD
G
WNT5A
wingless-type MMTV integration site family, member 5A
decreases expression
ISO
3
55,499,743
55,521,670
RGD:6480464
CTD
G
WNT7A
wingless-type MMTV integration site family, member 7A
decreases expression
EXP
3
13,860,082
13,921,618
RGD:6480464
CTD
G
XDH
xanthine dehydrogenase
increases expression
ISO
2
31,557,188
31,637,611
RGD:6480464
CTD
G
XIAP
X-linked inhibitor of apoptosis
multiple interactions
EXP
X
122,993,662
123,047,829
RGD:6480464
CTD
G
XIAP
X-linked inhibitor of apoptosis
decreases expression
EXP
X
122,993,662
123,047,829
RGD:6480464
CTD
G
XIAP
X-linked inhibitor of apoptosis
multiple interactions
EXP
X
122,993,662
123,047,829
RGD:6480464
CTD
G
XRCC1
X-ray repair complementing defective repair in Chinese hamster cells 1
decreases expression
ISO
19
44,047,464
44,079,730
RGD:6480464
CTD
G
YPEL5
yippee-like 5 (Drosophila)
decreases expression
EXP
2
30,369,750
30,383,399
RGD:6480464
CTD
G
ZC3H10
zinc finger CCCH-type containing 10
increases expression
EXP
12
56,512,030
56,516,278
RGD:6480464
CTD
G
ZEB1
zinc finger E-box binding homeobox 1
decreases expression
ISO
10
31,608,101
31,818,742
RGD:6480464
CTD
G
ZFP36L1
ZFP36 ring finger protein-like 1
decreases expression
EXP
14
69,254,372
69,262,960
RGD:6480464
CTD
G
ZFPM2
zinc finger protein, FOG family member 2
decreases expression
EXP
8
106,331,147
106,816,767
RGD:6480464
CTD
G
ZKSCAN2
zinc finger with KRAB and SCAN domains 2
increases expression
EXP
16
25,247,322
25,268,855
RGD:6480464
CTD
G
ZMYM3
zinc finger, MYM-type 3
increases expression
EXP
X
70,459,474
70,475,047
RGD:6480464
CTD
G
ZNF177
zinc finger protein 177
increases expression
EXP
19
9,473,696
9,493,293
RGD:6480464
CTD
G
ZNF354A
zinc finger protein 354A
decreases expression
ISO
5
178,138,522
178,157,703
RGD:6480464
CTD
G
ZNF37A
zinc finger protein 37A
decreases expression
EXP
10
38,383,264
38,412,280
RGD:6480464
CTD
G
ZNF703
zinc finger protein 703
increases expression
EXP
8
37,553,301
37,556,396
RGD:6480464
CTD
G
ZWINT
ZW10 interactor, kinetochore protein
increases expression
EXP
10
58,117,199
58,121,034
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest